3 Dow Stocks That Make for Screaming Buys in February

247
Comment
Favorite

3 Dow Stocks That Make for Screaming Buys in February

Motley Fool2023-02-04

KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

247

Report

Comment

天天有錢賺
·2023-02-04
Ok
Reply
2
Report
Fold Replies
- 天天有錢賺:
  Cool
  2023-02-04
  Reply
  Report
selwyn
·2023-02-04
Please like
Reply
4
Report
bostonxsgp
·2023-02-04
okay
Reply
4
Report
Fold Replies
- selwyn:
  k
  2023-02-04
  Reply
  Report
- bostonxsgp:
  ups
  2023-02-04
  Reply
  Report
Seah CL
·2023-02-04
K
Reply
3
Report
pinky557
·2023-02-04
Ok
Reply
2
Report
Fiona888
·2023-02-04
Yes
Reply
4
Report
Fold Replies
- Fiona888:
  k
  2023-02-04
  Reply
  Report
Khoo18
·2023-02-04
K
Reply
7
Report
kkennn
·2023-02-04
Ok
Reply
7
Report
Fold Replies
- Khoo18:
  k
  2023-02-04
  Reply
  Report
PooYen
·2023-02-04
[Happy] [Happy] [Happy] [Happy] [Happy]
Reply
6
Report
Azzu
·2023-02-04
[Cool]
Reply
6
Report
phantom74
·2023-02-04
ok
Reply
7
Report
Fold Replies
- kkennn:
  Ok
  2023-02-04
  Reply
  Report
KCtan1688
·2023-02-04
Like
Reply
7
Report
Fold Replies
- KCtan1688:
  Like
  2023-02-04
  Reply
  Report
Aidukas
·2023-02-04
Visa good for nothing.
Reply
7
Report
Fold Replies
- Azzu:
  [Cool]
  2023-02-04
  Reply
  Report
June_C
·2023-02-04
Great
Reply
10
Report
LimBT
·2023-02-03
Ok
Reply
19
Report
SNeo
·2023-02-03
[OK]
Reply
13
Report
Aivern
·2023-02-03
Lol garbage
Reply
9
Report
JQC
·2023-02-03
Ok
Reply
14
Report
Fold Replies
- MilkyMiao:
  Ok
  2023-02-04
  Reply
  Report
- Zeruel:
  😡
  2023-02-04
  Reply
  Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1158764094?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-02-04 00:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1158764094","market":"us","top_or_hot":-1,"title":"3 Dow Stocks That Make for Screaming Buys in February","media":"Motley Fool","content":"<div>\n<p>KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/\">Source Link</a>\n\n</div>\n","source":"fool_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Dow Stocks That Make for Screaming Buys in February</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Dow Stocks That Make for Screaming Buys in February\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-02-04 00:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VZ","symbol_name":"威瑞森","start_time":0,"source_url":"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/","article_id":"1158764094","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1158764094","pubTimestamp":1675440053,"sourceInfo":{"source_id":"fool_stock","name":"Motley Fool"},"weMediaInfo":null,"summary":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock inde","collect":0,"end_time":0,"defaultTopTitle":"fool.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"VZ":"威瑞森","V":"Visa","JNJ":"强生"},"translate_title":"2月份令人叫绝的3只道琼斯股票","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JNJ":0.9,"V":0.9,"VZ":0.9},"content_text":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.These three Dow stocks offer bountiful catalysts and are reasonably cheap.Out of the Dow Jones Industrial Average's 30 components, there are three amazing deals hiding in plain sight.It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably \"better\" than the 19% and 33% respective declines delivered by the S&P 500 and Nasdaq Composite in 2022.Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it's well equipped to deal with stock market downturns. It's also a great place to look for investing ideas during a bear market.As we motor ahead into February, the following three Dow stocks stand out as screaming buys.VisaThe first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.The biggest knock against Visa is that it's cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa's shareholders.Something else that doesn't hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.But don't think for a moment the U.S. is Visa's only organic growth opportunity. There's a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa's cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.Another key investment thesis with Visa that I've driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.With Visa valued at 24 times Wall Street's consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.Verizon CommunicationsA second Dow stock that's nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.One factor clearly working in Verizon's favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don't meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company's wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.But the unsung hero for Verizon might just be the resurgence it's seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon's operating cash flow and improve its operating margins.Currently valued at a little over 8 times Wall Street's forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.Johnson & JohnsonThe third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson & Johnson (JNJ 0.38%). J&J, as Johnson & Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can't decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It's this demand predictability that's kept Johnson & Johnson's profit needle pointing higher for decades.In terms of operating segments, pharmaceuticals are J&J's not-so-subtle secret to success. For more than a decade, Johnson & Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.If there's a potential downside to having more than half of its sales come from pharmaceuticals, it's that sales exclusivity for brand-name drugs is finite. But J&J has all the right answers to this possible headwind. It's devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that's well positioned to take advantage of an aging global population.One of Johnson & Johnson's bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street's 2023 consensus), which is where it ended this past week.Lastly, Johnson & Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it's one of only two with the highest possible credit rating (AAA) from Standard & Poor's, a division of S&P Global. It's also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson & Johnson.","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[{"id":9955267362,"gmtCreate":1675467697056,"gmtModify":1676539004506,"author":{"id":"3569157961325264","authorId":"3569157961325264","name":"天天有錢賺","avatar":"https://static.tigerbbs.com/a87d6821c87a3f5345fd3b39e87a3710","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9955267362","repostId":1158764094,"repostType":4,"repost":{"id":"1158764094","pubTimestamp":1675440053,"share":"https://www.laohu8.com/m/news/1158764094?lang=&edition=full","pubTime":"2023-02-04 00:00","market":"us","language":"en","title":"3 Dow Stocks That Make for Screaming Buys in February","url":"https://stock-news.laohu8.com/highlight/detail?id=1158764094","media":"Motley Fool","summary":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock inde","content":"<html><head></head><body><h3>KEY POINTS</h3><ul><li>The 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.</li><li>The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.</li><li>These three Dow stocks offer bountiful catalysts and are reasonably cheap.</li></ul><p>Out of the Dow Jones Industrial Average&#39;s 30 components, there are three amazing deals hiding in plain sight.</p><p>It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.</p><p>But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably &#34;better&#34; than the 19% and 33% respective declines delivered by the S&amp;P 500 and Nasdaq Composite in 2022.</p><p>Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it&#39;s well equipped to deal with stock market downturns. It&#39;s also a great place to look for investing ideas during a bear market.</p><p>As we motor ahead into February, the following three Dow stocks stand out as screaming buys.</p><h3><a href=\"https://laohu8.com/S/V\">Visa</a></h3><p>The first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.</p><p>The biggest knock against Visa is that it&#39;s cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.</p><p>What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa&#39;s shareholders.</p><p>Something else that doesn&#39;t hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.</p><p>But don&#39;t think for a moment the U.S. is Visa&#39;s only organic growth opportunity. There&#39;s a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa&#39;s cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.</p><p>Another key investment thesis with Visa that I&#39;ve driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.</p><p>With Visa valued at 24 times Wall Street&#39;s consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.</p><h3><a href=\"https://laohu8.com/S/VZ\">Verizon Communications</a></h3><p>A second Dow stock that&#39;s nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).</p><p>For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.</p><p>One factor clearly working in Verizon&#39;s favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don&#39;t meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.</p><p>The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company&#39;s wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.</p><p>But the unsung hero for Verizon might just be the resurgence it&#39;s seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon&#39;s operating cash flow and improve its operating margins.</p><p>Currently valued at a little over 8 times Wall Street&#39;s forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.</p><h3><a href=\"https://laohu8.com/S/JNJ\">Johnson &amp; Johnson</a></h3><p>The third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson &amp; Johnson (JNJ 0.38%). J&amp;J, as Johnson &amp; Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.</p><p>Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can&#39;t decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It&#39;s this demand predictability that&#39;s kept Johnson &amp; Johnson&#39;s profit needle pointing higher for decades.</p><p>In terms of operating segments, pharmaceuticals are J&amp;J&#39;s not-so-subtle secret to success. For more than a decade, Johnson &amp; Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.</p><p>If there&#39;s a potential downside to having more than half of its sales come from pharmaceuticals, it&#39;s that sales exclusivity for brand-name drugs is finite. But J&amp;J has all the right answers to this possible headwind. It&#39;s devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that&#39;s well positioned to take advantage of an aging global population.</p><p>One of Johnson &amp; Johnson&#39;s bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&amp;J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street&#39;s 2023 consensus), which is where it ended this past week.</p><p>Lastly, Johnson &amp; Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it&#39;s one of only two with the highest possible credit rating (AAA) from Standard &amp; Poor&#39;s, a division of S&amp;P Global. It&#39;s also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson &amp; Johnson.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Dow Stocks That Make for Screaming Buys in February</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Dow Stocks That Make for Screaming Buys in February\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-02-04 00:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"V":"Visa","VZ":"威瑞森","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158764094","content_text":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.These three Dow stocks offer bountiful catalysts and are reasonably cheap.Out of the Dow Jones Industrial Average's 30 components, there are three amazing deals hiding in plain sight.It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably \"better\" than the 19% and 33% respective declines delivered by the S&P 500 and Nasdaq Composite in 2022.Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it's well equipped to deal with stock market downturns. It's also a great place to look for investing ideas during a bear market.As we motor ahead into February, the following three Dow stocks stand out as screaming buys.VisaThe first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.The biggest knock against Visa is that it's cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa's shareholders.Something else that doesn't hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.But don't think for a moment the U.S. is Visa's only organic growth opportunity. There's a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa's cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.Another key investment thesis with Visa that I've driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.With Visa valued at 24 times Wall Street's consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.Verizon CommunicationsA second Dow stock that's nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.One factor clearly working in Verizon's favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don't meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company's wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.But the unsung hero for Verizon might just be the resurgence it's seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon's operating cash flow and improve its operating margins.Currently valued at a little over 8 times Wall Street's forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.Johnson & JohnsonThe third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson & Johnson (JNJ 0.38%). J&J, as Johnson & Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can't decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It's this demand predictability that's kept Johnson & Johnson's profit needle pointing higher for decades.In terms of operating segments, pharmaceuticals are J&J's not-so-subtle secret to success. For more than a decade, Johnson & Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.If there's a potential downside to having more than half of its sales come from pharmaceuticals, it's that sales exclusivity for brand-name drugs is finite. But J&J has all the right answers to this possible headwind. It's devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that's well positioned to take advantage of an aging global population.One of Johnson & Johnson's bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street's 2023 consensus), which is where it ended this past week.Lastly, Johnson & Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it's one of only two with the highest possible credit rating (AAA) from Standard & Poor's, a division of S&P Global. It's also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson & Johnson.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":105719091,"gmtCreate":1675467701919,"gmtModify":1675467723926,"authorId":3569157961325264,"author":{"id":3569157961325264,"authorId":3569157961325264,"name":"天天有錢賺","avatar":"https://static.tigerbbs.com/a87d6821c87a3f5345fd3b39e87a3710","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9955267362,"type":1,"supId":0,"prevId":0,"content":"<u>Cool</u>","text":"<u>Cool</u>","html":"<u>Cool</u>"}],"langContent":"EN"},{"id":9955265064,"gmtCreate":1675467479759,"gmtModify":1676539004440,"author":{"id":"3555362771681553","authorId":"3555362771681553","name":"selwyn","avatar":"https://static.tigerbbs.com/a7e6473ec2cec348d167d7d95fbdb76c","vip":1,"crmLevel":7,"crmLevelSwitch":0},"htmlText":"Please like&nbsp;","listText":"Please like&nbsp;","text":"Please like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9955265064","repostId":1158764094,"repostType":4,"repost":{"id":"1158764094","pubTimestamp":1675440053,"share":"https://www.laohu8.com/m/news/1158764094?lang=&edition=full","pubTime":"2023-02-04 00:00","market":"us","language":"en","title":"3 Dow Stocks That Make for Screaming Buys in February","url":"https://stock-news.laohu8.com/highlight/detail?id=1158764094","media":"Motley Fool","summary":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock inde","content":"<html><head></head><body><h3>KEY POINTS</h3><ul><li>The 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.</li><li>The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.</li><li>These three Dow stocks offer bountiful catalysts and are reasonably cheap.</li></ul><p>Out of the Dow Jones Industrial Average&#39;s 30 components, there are three amazing deals hiding in plain sight.</p><p>It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.</p><p>But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably &#34;better&#34; than the 19% and 33% respective declines delivered by the S&amp;P 500 and Nasdaq Composite in 2022.</p><p>Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it&#39;s well equipped to deal with stock market downturns. It&#39;s also a great place to look for investing ideas during a bear market.</p><p>As we motor ahead into February, the following three Dow stocks stand out as screaming buys.</p><h3><a href=\"https://laohu8.com/S/V\">Visa</a></h3><p>The first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.</p><p>The biggest knock against Visa is that it&#39;s cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.</p><p>What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa&#39;s shareholders.</p><p>Something else that doesn&#39;t hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.</p><p>But don&#39;t think for a moment the U.S. is Visa&#39;s only organic growth opportunity. There&#39;s a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa&#39;s cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.</p><p>Another key investment thesis with Visa that I&#39;ve driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.</p><p>With Visa valued at 24 times Wall Street&#39;s consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.</p><h3><a href=\"https://laohu8.com/S/VZ\">Verizon Communications</a></h3><p>A second Dow stock that&#39;s nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).</p><p>For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.</p><p>One factor clearly working in Verizon&#39;s favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don&#39;t meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.</p><p>The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company&#39;s wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.</p><p>But the unsung hero for Verizon might just be the resurgence it&#39;s seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon&#39;s operating cash flow and improve its operating margins.</p><p>Currently valued at a little over 8 times Wall Street&#39;s forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.</p><h3><a href=\"https://laohu8.com/S/JNJ\">Johnson &amp; Johnson</a></h3><p>The third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson &amp; Johnson (JNJ 0.38%). J&amp;J, as Johnson &amp; Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.</p><p>Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can&#39;t decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It&#39;s this demand predictability that&#39;s kept Johnson &amp; Johnson&#39;s profit needle pointing higher for decades.</p><p>In terms of operating segments, pharmaceuticals are J&amp;J&#39;s not-so-subtle secret to success. For more than a decade, Johnson &amp; Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.</p><p>If there&#39;s a potential downside to having more than half of its sales come from pharmaceuticals, it&#39;s that sales exclusivity for brand-name drugs is finite. But J&amp;J has all the right answers to this possible headwind. It&#39;s devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that&#39;s well positioned to take advantage of an aging global population.</p><p>One of Johnson &amp; Johnson&#39;s bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&amp;J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street&#39;s 2023 consensus), which is where it ended this past week.</p><p>Lastly, Johnson &amp; Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it&#39;s one of only two with the highest possible credit rating (AAA) from Standard &amp; Poor&#39;s, a division of S&amp;P Global. It&#39;s also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson &amp; Johnson.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Dow Stocks That Make for Screaming Buys in February</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Dow Stocks That Make for Screaming Buys in February\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-02-04 00:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"V":"Visa","VZ":"威瑞森","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158764094","content_text":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.These three Dow stocks offer bountiful catalysts and are reasonably cheap.Out of the Dow Jones Industrial Average's 30 components, there are three amazing deals hiding in plain sight.It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably \"better\" than the 19% and 33% respective declines delivered by the S&P 500 and Nasdaq Composite in 2022.Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it's well equipped to deal with stock market downturns. It's also a great place to look for investing ideas during a bear market.As we motor ahead into February, the following three Dow stocks stand out as screaming buys.VisaThe first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.The biggest knock against Visa is that it's cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa's shareholders.Something else that doesn't hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.But don't think for a moment the U.S. is Visa's only organic growth opportunity. There's a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa's cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.Another key investment thesis with Visa that I've driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.With Visa valued at 24 times Wall Street's consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.Verizon CommunicationsA second Dow stock that's nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.One factor clearly working in Verizon's favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don't meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company's wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.But the unsung hero for Verizon might just be the resurgence it's seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon's operating cash flow and improve its operating margins.Currently valued at a little over 8 times Wall Street's forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.Johnson & JohnsonThe third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson & Johnson (JNJ 0.38%). J&J, as Johnson & Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can't decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It's this demand predictability that's kept Johnson & Johnson's profit needle pointing higher for decades.In terms of operating segments, pharmaceuticals are J&J's not-so-subtle secret to success. For more than a decade, Johnson & Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.If there's a potential downside to having more than half of its sales come from pharmaceuticals, it's that sales exclusivity for brand-name drugs is finite. But J&J has all the right answers to this possible headwind. It's devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that's well positioned to take advantage of an aging global population.One of Johnson & Johnson's bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street's 2023 consensus), which is where it ended this past week.Lastly, Johnson & Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it's one of only two with the highest possible credit rating (AAA) from Standard & Poor's, a division of S&P Global. It's also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson & Johnson.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9955266256,"gmtCreate":1675467042076,"gmtModify":1676539004399,"author":{"id":"3584157491931754","authorId":"3584157491931754","name":"bostonxsgp","avatar":"https://static.tigerbbs.com/55d82efabeabddb18cc2d6ca7a71a36f","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"okay","listText":"okay","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/9955266256","repostId":1158764094,"repostType":4,"repost":{"id":"1158764094","pubTimestamp":1675440053,"share":"https://www.laohu8.com/m/news/1158764094?lang=&edition=full","pubTime":"2023-02-04 00:00","market":"us","language":"en","title":"3 Dow Stocks That Make for Screaming Buys in February","url":"https://stock-news.laohu8.com/highlight/detail?id=1158764094","media":"Motley Fool","summary":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock inde","content":"<html><head></head><body><h3>KEY POINTS</h3><ul><li>The 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.</li><li>The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.</li><li>These three Dow stocks offer bountiful catalysts and are reasonably cheap.</li></ul><p>Out of the Dow Jones Industrial Average&#39;s 30 components, there are three amazing deals hiding in plain sight.</p><p>It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.</p><p>But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably &#34;better&#34; than the 19% and 33% respective declines delivered by the S&amp;P 500 and Nasdaq Composite in 2022.</p><p>Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it&#39;s well equipped to deal with stock market downturns. It&#39;s also a great place to look for investing ideas during a bear market.</p><p>As we motor ahead into February, the following three Dow stocks stand out as screaming buys.</p><h3><a href=\"https://laohu8.com/S/V\">Visa</a></h3><p>The first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.</p><p>The biggest knock against Visa is that it&#39;s cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.</p><p>What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa&#39;s shareholders.</p><p>Something else that doesn&#39;t hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.</p><p>But don&#39;t think for a moment the U.S. is Visa&#39;s only organic growth opportunity. There&#39;s a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa&#39;s cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.</p><p>Another key investment thesis with Visa that I&#39;ve driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.</p><p>With Visa valued at 24 times Wall Street&#39;s consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.</p><h3><a href=\"https://laohu8.com/S/VZ\">Verizon Communications</a></h3><p>A second Dow stock that&#39;s nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).</p><p>For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.</p><p>One factor clearly working in Verizon&#39;s favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don&#39;t meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.</p><p>The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company&#39;s wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.</p><p>But the unsung hero for Verizon might just be the resurgence it&#39;s seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon&#39;s operating cash flow and improve its operating margins.</p><p>Currently valued at a little over 8 times Wall Street&#39;s forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.</p><h3><a href=\"https://laohu8.com/S/JNJ\">Johnson &amp; Johnson</a></h3><p>The third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson &amp; Johnson (JNJ 0.38%). J&amp;J, as Johnson &amp; Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.</p><p>Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can&#39;t decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It&#39;s this demand predictability that&#39;s kept Johnson &amp; Johnson&#39;s profit needle pointing higher for decades.</p><p>In terms of operating segments, pharmaceuticals are J&amp;J&#39;s not-so-subtle secret to success. For more than a decade, Johnson &amp; Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.</p><p>If there&#39;s a potential downside to having more than half of its sales come from pharmaceuticals, it&#39;s that sales exclusivity for brand-name drugs is finite. But J&amp;J has all the right answers to this possible headwind. It&#39;s devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that&#39;s well positioned to take advantage of an aging global population.</p><p>One of Johnson &amp; Johnson&#39;s bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&amp;J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street&#39;s 2023 consensus), which is where it ended this past week.</p><p>Lastly, Johnson &amp; Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it&#39;s one of only two with the highest possible credit rating (AAA) from Standard &amp; Poor&#39;s, a division of S&amp;P Global. It&#39;s also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson &amp; Johnson.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Dow Stocks That Make for Screaming Buys in February</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Dow Stocks That Make for Screaming Buys in February\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-02-04 00:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"V":"Visa","VZ":"威瑞森","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158764094","content_text":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.These three Dow stocks offer bountiful catalysts and are reasonably cheap.Out of the Dow Jones Industrial Average's 30 components, there are three amazing deals hiding in plain sight.It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably \"better\" than the 19% and 33% respective declines delivered by the S&P 500 and Nasdaq Composite in 2022.Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it's well equipped to deal with stock market downturns. It's also a great place to look for investing ideas during a bear market.As we motor ahead into February, the following three Dow stocks stand out as screaming buys.VisaThe first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.The biggest knock against Visa is that it's cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa's shareholders.Something else that doesn't hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.But don't think for a moment the U.S. is Visa's only organic growth opportunity. There's a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa's cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.Another key investment thesis with Visa that I've driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.With Visa valued at 24 times Wall Street's consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.Verizon CommunicationsA second Dow stock that's nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.One factor clearly working in Verizon's favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don't meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company's wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.But the unsung hero for Verizon might just be the resurgence it's seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon's operating cash flow and improve its operating margins.Currently valued at a little over 8 times Wall Street's forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.Johnson & JohnsonThe third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson & Johnson (JNJ 0.38%). J&J, as Johnson & Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can't decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It's this demand predictability that's kept Johnson & Johnson's profit needle pointing higher for decades.In terms of operating segments, pharmaceuticals are J&J's not-so-subtle secret to success. For more than a decade, Johnson & Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.If there's a potential downside to having more than half of its sales come from pharmaceuticals, it's that sales exclusivity for brand-name drugs is finite. But J&J has all the right answers to this possible headwind. It's devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that's well positioned to take advantage of an aging global population.One of Johnson & Johnson's bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street's 2023 consensus), which is where it ended this past week.Lastly, Johnson & Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it's one of only two with the highest possible credit rating (AAA) from Standard & Poor's, a division of S&P Global. It's also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson & Johnson.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":105719072,"gmtCreate":1675467484846,"gmtModify":1675467488039,"authorId":3555362771681553,"author":{"id":3555362771681553,"authorId":3555362771681553,"name":"selwyn","avatar":"https://static.tigerbbs.com/a7e6473ec2cec348d167d7d95fbdb76c","vip":1,"crmLevel":7,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9955266256,"type":1,"supId":0,"prevId":0,"content":"<u>k</u>","text":"<u>k</u>","html":"<u>k</u>"},{"id":105719064,"gmtCreate":1675467055734,"gmtModify":1675467059769,"authorId":3584157491931754,"author":{"id":3584157491931754,"authorId":3584157491931754,"name":"bostonxsgp","avatar":"https://static.tigerbbs.com/55d82efabeabddb18cc2d6ca7a71a36f","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.54%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9955266256,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">ups</span>","text":"<span class=\"s1\">ups</span>","html":"<span class=\"s1\">ups</span>"}],"langContent":"EN"},{"id":9955268582,"gmtCreate":1675466587746,"gmtModify":1676539004376,"author":{"id":"4102135564535180","authorId":"4102135564535180","name":"Seah CL","avatar":"https://community-static.tradeup.com/news/970bca7b04e85a42a2c8eabed7ec96d0","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9955268582","repostId":1158764094,"repostType":4,"repost":{"id":"1158764094","pubTimestamp":1675440053,"share":"https://www.laohu8.com/m/news/1158764094?lang=&edition=full","pubTime":"2023-02-04 00:00","market":"us","language":"en","title":"3 Dow Stocks That Make for Screaming Buys in February","url":"https://stock-news.laohu8.com/highlight/detail?id=1158764094","media":"Motley Fool","summary":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock inde","content":"<html><head></head><body><h3>KEY POINTS</h3><ul><li>The 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.</li><li>The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.</li><li>These three Dow stocks offer bountiful catalysts and are reasonably cheap.</li></ul><p>Out of the Dow Jones Industrial Average&#39;s 30 components, there are three amazing deals hiding in plain sight.</p><p>It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.</p><p>But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably &#34;better&#34; than the 19% and 33% respective declines delivered by the S&amp;P 500 and Nasdaq Composite in 2022.</p><p>Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it&#39;s well equipped to deal with stock market downturns. It&#39;s also a great place to look for investing ideas during a bear market.</p><p>As we motor ahead into February, the following three Dow stocks stand out as screaming buys.</p><h3><a href=\"https://laohu8.com/S/V\">Visa</a></h3><p>The first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.</p><p>The biggest knock against Visa is that it&#39;s cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.</p><p>What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa&#39;s shareholders.</p><p>Something else that doesn&#39;t hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.</p><p>But don&#39;t think for a moment the U.S. is Visa&#39;s only organic growth opportunity. There&#39;s a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa&#39;s cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.</p><p>Another key investment thesis with Visa that I&#39;ve driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.</p><p>With Visa valued at 24 times Wall Street&#39;s consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.</p><h3><a href=\"https://laohu8.com/S/VZ\">Verizon Communications</a></h3><p>A second Dow stock that&#39;s nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).</p><p>For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.</p><p>One factor clearly working in Verizon&#39;s favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don&#39;t meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.</p><p>The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company&#39;s wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.</p><p>But the unsung hero for Verizon might just be the resurgence it&#39;s seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon&#39;s operating cash flow and improve its operating margins.</p><p>Currently valued at a little over 8 times Wall Street&#39;s forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.</p><h3><a href=\"https://laohu8.com/S/JNJ\">Johnson &amp; Johnson</a></h3><p>The third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson &amp; Johnson (JNJ 0.38%). J&amp;J, as Johnson &amp; Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.</p><p>Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can&#39;t decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It&#39;s this demand predictability that&#39;s kept Johnson &amp; Johnson&#39;s profit needle pointing higher for decades.</p><p>In terms of operating segments, pharmaceuticals are J&amp;J&#39;s not-so-subtle secret to success. For more than a decade, Johnson &amp; Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.</p><p>If there&#39;s a potential downside to having more than half of its sales come from pharmaceuticals, it&#39;s that sales exclusivity for brand-name drugs is finite. But J&amp;J has all the right answers to this possible headwind. It&#39;s devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that&#39;s well positioned to take advantage of an aging global population.</p><p>One of Johnson &amp; Johnson&#39;s bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&amp;J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street&#39;s 2023 consensus), which is where it ended this past week.</p><p>Lastly, Johnson &amp; Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it&#39;s one of only two with the highest possible credit rating (AAA) from Standard &amp; Poor&#39;s, a division of S&amp;P Global. It&#39;s also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson &amp; Johnson.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Dow Stocks That Make for Screaming Buys in February</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Dow Stocks That Make for Screaming Buys in February\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-02-04 00:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"V":"Visa","VZ":"威瑞森","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158764094","content_text":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.These three Dow stocks offer bountiful catalysts and are reasonably cheap.Out of the Dow Jones Industrial Average's 30 components, there are three amazing deals hiding in plain sight.It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably \"better\" than the 19% and 33% respective declines delivered by the S&P 500 and Nasdaq Composite in 2022.Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it's well equipped to deal with stock market downturns. It's also a great place to look for investing ideas during a bear market.As we motor ahead into February, the following three Dow stocks stand out as screaming buys.VisaThe first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.The biggest knock against Visa is that it's cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa's shareholders.Something else that doesn't hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.But don't think for a moment the U.S. is Visa's only organic growth opportunity. There's a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa's cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.Another key investment thesis with Visa that I've driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.With Visa valued at 24 times Wall Street's consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.Verizon CommunicationsA second Dow stock that's nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.One factor clearly working in Verizon's favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don't meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company's wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.But the unsung hero for Verizon might just be the resurgence it's seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon's operating cash flow and improve its operating margins.Currently valued at a little over 8 times Wall Street's forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.Johnson & JohnsonThe third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson & Johnson (JNJ 0.38%). J&J, as Johnson & Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can't decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It's this demand predictability that's kept Johnson & Johnson's profit needle pointing higher for decades.In terms of operating segments, pharmaceuticals are J&J's not-so-subtle secret to success. For more than a decade, Johnson & Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.If there's a potential downside to having more than half of its sales come from pharmaceuticals, it's that sales exclusivity for brand-name drugs is finite. But J&J has all the right answers to this possible headwind. It's devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that's well positioned to take advantage of an aging global population.One of Johnson & Johnson's bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street's 2023 consensus), which is where it ended this past week.Lastly, Johnson & Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it's one of only two with the highest possible credit rating (AAA) from Standard & Poor's, a division of S&P Global. It's also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson & Johnson.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9955268698,"gmtCreate":1675466486114,"gmtModify":1676539004370,"author":{"id":"4091530726290800","authorId":"4091530726290800","name":"pinky557","avatar":"https://static.tigerbbs.com/cc428593461c0ba93003c3e2c7fc8439","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9955268698","repostId":1158764094,"repostType":4,"repost":{"id":"1158764094","pubTimestamp":1675440053,"share":"https://www.laohu8.com/m/news/1158764094?lang=&edition=full","pubTime":"2023-02-04 00:00","market":"us","language":"en","title":"3 Dow Stocks That Make for Screaming Buys in February","url":"https://stock-news.laohu8.com/highlight/detail?id=1158764094","media":"Motley Fool","summary":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock inde","content":"<html><head></head><body><h3>KEY POINTS</h3><ul><li>The 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.</li><li>The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.</li><li>These three Dow stocks offer bountiful catalysts and are reasonably cheap.</li></ul><p>Out of the Dow Jones Industrial Average&#39;s 30 components, there are three amazing deals hiding in plain sight.</p><p>It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.</p><p>But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably &#34;better&#34; than the 19% and 33% respective declines delivered by the S&amp;P 500 and Nasdaq Composite in 2022.</p><p>Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it&#39;s well equipped to deal with stock market downturns. It&#39;s also a great place to look for investing ideas during a bear market.</p><p>As we motor ahead into February, the following three Dow stocks stand out as screaming buys.</p><h3><a href=\"https://laohu8.com/S/V\">Visa</a></h3><p>The first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.</p><p>The biggest knock against Visa is that it&#39;s cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.</p><p>What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa&#39;s shareholders.</p><p>Something else that doesn&#39;t hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.</p><p>But don&#39;t think for a moment the U.S. is Visa&#39;s only organic growth opportunity. There&#39;s a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa&#39;s cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.</p><p>Another key investment thesis with Visa that I&#39;ve driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.</p><p>With Visa valued at 24 times Wall Street&#39;s consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.</p><h3><a href=\"https://laohu8.com/S/VZ\">Verizon Communications</a></h3><p>A second Dow stock that&#39;s nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).</p><p>For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.</p><p>One factor clearly working in Verizon&#39;s favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don&#39;t meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.</p><p>The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company&#39;s wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.</p><p>But the unsung hero for Verizon might just be the resurgence it&#39;s seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon&#39;s operating cash flow and improve its operating margins.</p><p>Currently valued at a little over 8 times Wall Street&#39;s forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.</p><h3><a href=\"https://laohu8.com/S/JNJ\">Johnson &amp; Johnson</a></h3><p>The third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson &amp; Johnson (JNJ 0.38%). J&amp;J, as Johnson &amp; Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.</p><p>Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can&#39;t decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It&#39;s this demand predictability that&#39;s kept Johnson &amp; Johnson&#39;s profit needle pointing higher for decades.</p><p>In terms of operating segments, pharmaceuticals are J&amp;J&#39;s not-so-subtle secret to success. For more than a decade, Johnson &amp; Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.</p><p>If there&#39;s a potential downside to having more than half of its sales come from pharmaceuticals, it&#39;s that sales exclusivity for brand-name drugs is finite. But J&amp;J has all the right answers to this possible headwind. It&#39;s devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that&#39;s well positioned to take advantage of an aging global population.</p><p>One of Johnson &amp; Johnson&#39;s bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&amp;J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street&#39;s 2023 consensus), which is where it ended this past week.</p><p>Lastly, Johnson &amp; Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it&#39;s one of only two with the highest possible credit rating (AAA) from Standard &amp; Poor&#39;s, a division of S&amp;P Global. It&#39;s also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson &amp; Johnson.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Dow Stocks That Make for Screaming Buys in February</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Dow Stocks That Make for Screaming Buys in February\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-02-04 00:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"V":"Visa","VZ":"威瑞森","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158764094","content_text":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.These three Dow stocks offer bountiful catalysts and are reasonably cheap.Out of the Dow Jones Industrial Average's 30 components, there are three amazing deals hiding in plain sight.It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably \"better\" than the 19% and 33% respective declines delivered by the S&P 500 and Nasdaq Composite in 2022.Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it's well equipped to deal with stock market downturns. It's also a great place to look for investing ideas during a bear market.As we motor ahead into February, the following three Dow stocks stand out as screaming buys.VisaThe first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.The biggest knock against Visa is that it's cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa's shareholders.Something else that doesn't hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.But don't think for a moment the U.S. is Visa's only organic growth opportunity. There's a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa's cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.Another key investment thesis with Visa that I've driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.With Visa valued at 24 times Wall Street's consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.Verizon CommunicationsA second Dow stock that's nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.One factor clearly working in Verizon's favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don't meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company's wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.But the unsung hero for Verizon might just be the resurgence it's seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon's operating cash flow and improve its operating margins.Currently valued at a little over 8 times Wall Street's forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.Johnson & JohnsonThe third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson & Johnson (JNJ 0.38%). J&J, as Johnson & Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can't decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It's this demand predictability that's kept Johnson & Johnson's profit needle pointing higher for decades.In terms of operating segments, pharmaceuticals are J&J's not-so-subtle secret to success. For more than a decade, Johnson & Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.If there's a potential downside to having more than half of its sales come from pharmaceuticals, it's that sales exclusivity for brand-name drugs is finite. But J&J has all the right answers to this possible headwind. It's devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that's well positioned to take advantage of an aging global population.One of Johnson & Johnson's bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street's 2023 consensus), which is where it ended this past week.Lastly, Johnson & Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it's one of only two with the highest possible credit rating (AAA) from Standard & Poor's, a division of S&P Global. It's also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson & Johnson.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9955263867,"gmtCreate":1675465236459,"gmtModify":1676539004308,"author":{"id":"3581675432544786","authorId":"3581675432544786","name":"Fiona888","avatar":"https://static.tigerbbs.com/42688ec73bb74970876cdb05131f23f7","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":2,"crmLevelSwitch":0},"htmlText":"Yes","listText":"Yes","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9955263867","repostId":1158764094,"repostType":4,"repost":{"id":"1158764094","pubTimestamp":1675440053,"share":"https://www.laohu8.com/m/news/1158764094?lang=&edition=full","pubTime":"2023-02-04 00:00","market":"us","language":"en","title":"3 Dow Stocks That Make for Screaming Buys in February","url":"https://stock-news.laohu8.com/highlight/detail?id=1158764094","media":"Motley Fool","summary":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock inde","content":"<html><head></head><body><h3>KEY POINTS</h3><ul><li>The 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.</li><li>The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.</li><li>These three Dow stocks offer bountiful catalysts and are reasonably cheap.</li></ul><p>Out of the Dow Jones Industrial Average&#39;s 30 components, there are three amazing deals hiding in plain sight.</p><p>It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.</p><p>But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably &#34;better&#34; than the 19% and 33% respective declines delivered by the S&amp;P 500 and Nasdaq Composite in 2022.</p><p>Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it&#39;s well equipped to deal with stock market downturns. It&#39;s also a great place to look for investing ideas during a bear market.</p><p>As we motor ahead into February, the following three Dow stocks stand out as screaming buys.</p><h3><a href=\"https://laohu8.com/S/V\">Visa</a></h3><p>The first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.</p><p>The biggest knock against Visa is that it&#39;s cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.</p><p>What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa&#39;s shareholders.</p><p>Something else that doesn&#39;t hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.</p><p>But don&#39;t think for a moment the U.S. is Visa&#39;s only organic growth opportunity. There&#39;s a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa&#39;s cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.</p><p>Another key investment thesis with Visa that I&#39;ve driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.</p><p>With Visa valued at 24 times Wall Street&#39;s consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.</p><h3><a href=\"https://laohu8.com/S/VZ\">Verizon Communications</a></h3><p>A second Dow stock that&#39;s nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).</p><p>For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.</p><p>One factor clearly working in Verizon&#39;s favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don&#39;t meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.</p><p>The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company&#39;s wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.</p><p>But the unsung hero for Verizon might just be the resurgence it&#39;s seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon&#39;s operating cash flow and improve its operating margins.</p><p>Currently valued at a little over 8 times Wall Street&#39;s forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.</p><h3><a href=\"https://laohu8.com/S/JNJ\">Johnson &amp; Johnson</a></h3><p>The third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson &amp; Johnson (JNJ 0.38%). J&amp;J, as Johnson &amp; Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.</p><p>Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can&#39;t decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It&#39;s this demand predictability that&#39;s kept Johnson &amp; Johnson&#39;s profit needle pointing higher for decades.</p><p>In terms of operating segments, pharmaceuticals are J&amp;J&#39;s not-so-subtle secret to success. For more than a decade, Johnson &amp; Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.</p><p>If there&#39;s a potential downside to having more than half of its sales come from pharmaceuticals, it&#39;s that sales exclusivity for brand-name drugs is finite. But J&amp;J has all the right answers to this possible headwind. It&#39;s devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that&#39;s well positioned to take advantage of an aging global population.</p><p>One of Johnson &amp; Johnson&#39;s bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&amp;J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street&#39;s 2023 consensus), which is where it ended this past week.</p><p>Lastly, Johnson &amp; Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it&#39;s one of only two with the highest possible credit rating (AAA) from Standard &amp; Poor&#39;s, a division of S&amp;P Global. It&#39;s also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson &amp; Johnson.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Dow Stocks That Make for Screaming Buys in February</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Dow Stocks That Make for Screaming Buys in February\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-02-04 00:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"V":"Visa","VZ":"威瑞森","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158764094","content_text":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.These three Dow stocks offer bountiful catalysts and are reasonably cheap.Out of the Dow Jones Industrial Average's 30 components, there are three amazing deals hiding in plain sight.It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably \"better\" than the 19% and 33% respective declines delivered by the S&P 500 and Nasdaq Composite in 2022.Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it's well equipped to deal with stock market downturns. It's also a great place to look for investing ideas during a bear market.As we motor ahead into February, the following three Dow stocks stand out as screaming buys.VisaThe first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.The biggest knock against Visa is that it's cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa's shareholders.Something else that doesn't hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.But don't think for a moment the U.S. is Visa's only organic growth opportunity. There's a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa's cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.Another key investment thesis with Visa that I've driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.With Visa valued at 24 times Wall Street's consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.Verizon CommunicationsA second Dow stock that's nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.One factor clearly working in Verizon's favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don't meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company's wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.But the unsung hero for Verizon might just be the resurgence it's seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon's operating cash flow and improve its operating margins.Currently valued at a little over 8 times Wall Street's forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.Johnson & JohnsonThe third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson & Johnson (JNJ 0.38%). J&J, as Johnson & Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can't decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It's this demand predictability that's kept Johnson & Johnson's profit needle pointing higher for decades.In terms of operating segments, pharmaceuticals are J&J's not-so-subtle secret to success. For more than a decade, Johnson & Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.If there's a potential downside to having more than half of its sales come from pharmaceuticals, it's that sales exclusivity for brand-name drugs is finite. But J&J has all the right answers to this possible headwind. It's devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that's well positioned to take advantage of an aging global population.One of Johnson & Johnson's bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street's 2023 consensus), which is where it ended this past week.Lastly, Johnson & Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it's one of only two with the highest possible credit rating (AAA) from Standard & Poor's, a division of S&P Global. It's also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson & Johnson.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":105718988,"gmtCreate":1675465246062,"gmtModify":1675465259069,"authorId":3581675432544786,"author":{"id":3581675432544786,"authorId":3581675432544786,"name":"Fiona888","avatar":"https://static.tigerbbs.com/42688ec73bb74970876cdb05131f23f7","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9955263867,"type":1,"supId":0,"prevId":0,"content":"<u>k</u>","text":"<u>k</u>","html":"<u>k</u>"}],"langContent":"EN"},{"id":9955263355,"gmtCreate":1675465083278,"gmtModify":1676539004305,"author":{"id":"3586514899418238","authorId":"3586514899418238","name":"Khoo18","avatar":"https://static.tigerbbs.com/a895cde27a6f60014dacbbc8853a5e1e","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9955263355","repostId":1158764094,"repostType":4,"repost":{"id":"1158764094","pubTimestamp":1675440053,"share":"https://www.laohu8.com/m/news/1158764094?lang=&edition=full","pubTime":"2023-02-04 00:00","market":"us","language":"en","title":"3 Dow Stocks That Make for Screaming Buys in February","url":"https://stock-news.laohu8.com/highlight/detail?id=1158764094","media":"Motley Fool","summary":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock inde","content":"<html><head></head><body><h3>KEY POINTS</h3><ul><li>The 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.</li><li>The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.</li><li>These three Dow stocks offer bountiful catalysts and are reasonably cheap.</li></ul><p>Out of the Dow Jones Industrial Average&#39;s 30 components, there are three amazing deals hiding in plain sight.</p><p>It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.</p><p>But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably &#34;better&#34; than the 19% and 33% respective declines delivered by the S&amp;P 500 and Nasdaq Composite in 2022.</p><p>Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it&#39;s well equipped to deal with stock market downturns. It&#39;s also a great place to look for investing ideas during a bear market.</p><p>As we motor ahead into February, the following three Dow stocks stand out as screaming buys.</p><h3><a href=\"https://laohu8.com/S/V\">Visa</a></h3><p>The first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.</p><p>The biggest knock against Visa is that it&#39;s cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.</p><p>What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa&#39;s shareholders.</p><p>Something else that doesn&#39;t hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.</p><p>But don&#39;t think for a moment the U.S. is Visa&#39;s only organic growth opportunity. There&#39;s a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa&#39;s cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.</p><p>Another key investment thesis with Visa that I&#39;ve driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.</p><p>With Visa valued at 24 times Wall Street&#39;s consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.</p><h3><a href=\"https://laohu8.com/S/VZ\">Verizon Communications</a></h3><p>A second Dow stock that&#39;s nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).</p><p>For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.</p><p>One factor clearly working in Verizon&#39;s favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don&#39;t meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.</p><p>The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company&#39;s wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.</p><p>But the unsung hero for Verizon might just be the resurgence it&#39;s seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon&#39;s operating cash flow and improve its operating margins.</p><p>Currently valued at a little over 8 times Wall Street&#39;s forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.</p><h3><a href=\"https://laohu8.com/S/JNJ\">Johnson &amp; Johnson</a></h3><p>The third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson &amp; Johnson (JNJ 0.38%). J&amp;J, as Johnson &amp; Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.</p><p>Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can&#39;t decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It&#39;s this demand predictability that&#39;s kept Johnson &amp; Johnson&#39;s profit needle pointing higher for decades.</p><p>In terms of operating segments, pharmaceuticals are J&amp;J&#39;s not-so-subtle secret to success. For more than a decade, Johnson &amp; Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.</p><p>If there&#39;s a potential downside to having more than half of its sales come from pharmaceuticals, it&#39;s that sales exclusivity for brand-name drugs is finite. But J&amp;J has all the right answers to this possible headwind. It&#39;s devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that&#39;s well positioned to take advantage of an aging global population.</p><p>One of Johnson &amp; Johnson&#39;s bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&amp;J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street&#39;s 2023 consensus), which is where it ended this past week.</p><p>Lastly, Johnson &amp; Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it&#39;s one of only two with the highest possible credit rating (AAA) from Standard &amp; Poor&#39;s, a division of S&amp;P Global. It&#39;s also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson &amp; Johnson.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Dow Stocks That Make for Screaming Buys in February</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Dow Stocks That Make for Screaming Buys in February\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-02-04 00:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"V":"Visa","VZ":"威瑞森","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158764094","content_text":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.These three Dow stocks offer bountiful catalysts and are reasonably cheap.Out of the Dow Jones Industrial Average's 30 components, there are three amazing deals hiding in plain sight.It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably \"better\" than the 19% and 33% respective declines delivered by the S&P 500 and Nasdaq Composite in 2022.Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it's well equipped to deal with stock market downturns. It's also a great place to look for investing ideas during a bear market.As we motor ahead into February, the following three Dow stocks stand out as screaming buys.VisaThe first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.The biggest knock against Visa is that it's cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa's shareholders.Something else that doesn't hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.But don't think for a moment the U.S. is Visa's only organic growth opportunity. There's a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa's cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.Another key investment thesis with Visa that I've driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.With Visa valued at 24 times Wall Street's consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.Verizon CommunicationsA second Dow stock that's nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.One factor clearly working in Verizon's favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don't meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company's wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.But the unsung hero for Verizon might just be the resurgence it's seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon's operating cash flow and improve its operating margins.Currently valued at a little over 8 times Wall Street's forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.Johnson & JohnsonThe third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson & Johnson (JNJ 0.38%). J&J, as Johnson & Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can't decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It's this demand predictability that's kept Johnson & Johnson's profit needle pointing higher for decades.In terms of operating segments, pharmaceuticals are J&J's not-so-subtle secret to success. For more than a decade, Johnson & Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.If there's a potential downside to having more than half of its sales come from pharmaceuticals, it's that sales exclusivity for brand-name drugs is finite. But J&J has all the right answers to this possible headwind. It's devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that's well positioned to take advantage of an aging global population.One of Johnson & Johnson's bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street's 2023 consensus), which is where it ended this past week.Lastly, Johnson & Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it's one of only two with the highest possible credit rating (AAA) from Standard & Poor's, a division of S&P Global. It's also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson & Johnson.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9955269457,"gmtCreate":1675464553779,"gmtModify":1676539004292,"author":{"id":"3558617926022722","authorId":"3558617926022722","name":"kkennn","avatar":"https://static.tigerbbs.com/cfb6967409b5a69e663a7006e885e221","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9955269457","repostId":1158764094,"repostType":4,"repost":{"id":"1158764094","pubTimestamp":1675440053,"share":"https://www.laohu8.com/m/news/1158764094?lang=&edition=full","pubTime":"2023-02-04 00:00","market":"us","language":"en","title":"3 Dow Stocks That Make for Screaming Buys in February","url":"https://stock-news.laohu8.com/highlight/detail?id=1158764094","media":"Motley Fool","summary":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock inde","content":"<html><head></head><body><h3>KEY POINTS</h3><ul><li>The 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.</li><li>The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.</li><li>These three Dow stocks offer bountiful catalysts and are reasonably cheap.</li></ul><p>Out of the Dow Jones Industrial Average&#39;s 30 components, there are three amazing deals hiding in plain sight.</p><p>It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.</p><p>But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably &#34;better&#34; than the 19% and 33% respective declines delivered by the S&amp;P 500 and Nasdaq Composite in 2022.</p><p>Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it&#39;s well equipped to deal with stock market downturns. It&#39;s also a great place to look for investing ideas during a bear market.</p><p>As we motor ahead into February, the following three Dow stocks stand out as screaming buys.</p><h3><a href=\"https://laohu8.com/S/V\">Visa</a></h3><p>The first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.</p><p>The biggest knock against Visa is that it&#39;s cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.</p><p>What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa&#39;s shareholders.</p><p>Something else that doesn&#39;t hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.</p><p>But don&#39;t think for a moment the U.S. is Visa&#39;s only organic growth opportunity. There&#39;s a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa&#39;s cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.</p><p>Another key investment thesis with Visa that I&#39;ve driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.</p><p>With Visa valued at 24 times Wall Street&#39;s consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.</p><h3><a href=\"https://laohu8.com/S/VZ\">Verizon Communications</a></h3><p>A second Dow stock that&#39;s nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).</p><p>For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.</p><p>One factor clearly working in Verizon&#39;s favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don&#39;t meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.</p><p>The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company&#39;s wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.</p><p>But the unsung hero for Verizon might just be the resurgence it&#39;s seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon&#39;s operating cash flow and improve its operating margins.</p><p>Currently valued at a little over 8 times Wall Street&#39;s forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.</p><h3><a href=\"https://laohu8.com/S/JNJ\">Johnson &amp; Johnson</a></h3><p>The third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson &amp; Johnson (JNJ 0.38%). J&amp;J, as Johnson &amp; Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.</p><p>Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can&#39;t decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It&#39;s this demand predictability that&#39;s kept Johnson &amp; Johnson&#39;s profit needle pointing higher for decades.</p><p>In terms of operating segments, pharmaceuticals are J&amp;J&#39;s not-so-subtle secret to success. For more than a decade, Johnson &amp; Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.</p><p>If there&#39;s a potential downside to having more than half of its sales come from pharmaceuticals, it&#39;s that sales exclusivity for brand-name drugs is finite. But J&amp;J has all the right answers to this possible headwind. It&#39;s devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that&#39;s well positioned to take advantage of an aging global population.</p><p>One of Johnson &amp; Johnson&#39;s bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&amp;J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street&#39;s 2023 consensus), which is where it ended this past week.</p><p>Lastly, Johnson &amp; Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it&#39;s one of only two with the highest possible credit rating (AAA) from Standard &amp; Poor&#39;s, a division of S&amp;P Global. It&#39;s also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson &amp; Johnson.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Dow Stocks That Make for Screaming Buys in February</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Dow Stocks That Make for Screaming Buys in February\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-02-04 00:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"V":"Visa","VZ":"威瑞森","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158764094","content_text":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.These three Dow stocks offer bountiful catalysts and are reasonably cheap.Out of the Dow Jones Industrial Average's 30 components, there are three amazing deals hiding in plain sight.It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably \"better\" than the 19% and 33% respective declines delivered by the S&P 500 and Nasdaq Composite in 2022.Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it's well equipped to deal with stock market downturns. It's also a great place to look for investing ideas during a bear market.As we motor ahead into February, the following three Dow stocks stand out as screaming buys.VisaThe first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.The biggest knock against Visa is that it's cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa's shareholders.Something else that doesn't hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.But don't think for a moment the U.S. is Visa's only organic growth opportunity. There's a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa's cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.Another key investment thesis with Visa that I've driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.With Visa valued at 24 times Wall Street's consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.Verizon CommunicationsA second Dow stock that's nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.One factor clearly working in Verizon's favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don't meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company's wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.But the unsung hero for Verizon might just be the resurgence it's seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon's operating cash flow and improve its operating margins.Currently valued at a little over 8 times Wall Street's forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.Johnson & JohnsonThe third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson & Johnson (JNJ 0.38%). J&J, as Johnson & Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can't decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It's this demand predictability that's kept Johnson & Johnson's profit needle pointing higher for decades.In terms of operating segments, pharmaceuticals are J&J's not-so-subtle secret to success. For more than a decade, Johnson & Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.If there's a potential downside to having more than half of its sales come from pharmaceuticals, it's that sales exclusivity for brand-name drugs is finite. But J&J has all the right answers to this possible headwind. It's devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that's well positioned to take advantage of an aging global population.One of Johnson & Johnson's bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street's 2023 consensus), which is where it ended this past week.Lastly, Johnson & Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it's one of only two with the highest possible credit rating (AAA) from Standard & Poor's, a division of S&P Global. It's also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson & Johnson.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":105718977,"gmtCreate":1675465080169,"gmtModify":1675465112209,"authorId":3586514899418238,"author":{"id":3586514899418238,"authorId":3586514899418238,"name":"Khoo18","avatar":"https://static.tigerbbs.com/a895cde27a6f60014dacbbc8853a5e1e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9955269457,"type":1,"supId":0,"prevId":0,"content":"<u>k</u>","text":"<u>k</u>","html":"<u>k</u>"}],"langContent":"EN"},{"id":9955269295,"gmtCreate":1675464148018,"gmtModify":1676539004289,"author":{"id":"3576743360399762","authorId":"3576743360399762","name":"PooYen","avatar":"https://static.tigerbbs.com/90f2bad6620330727869f3a5a51a046a","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"[Happy]&nbsp;[Happy]&nbsp;[Happy]&nbsp;[Happy]&nbsp;[Happy]&nbsp;","listText":"[Happy]&nbsp;[Happy]&nbsp;[Happy]&nbsp;[Happy]&nbsp;[Happy]&nbsp;","text":"[Happy] [Happy] [Happy] [Happy] [Happy]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9955269295","repostId":1158764094,"repostType":4,"repost":{"id":"1158764094","pubTimestamp":1675440053,"share":"https://www.laohu8.com/m/news/1158764094?lang=&edition=full","pubTime":"2023-02-04 00:00","market":"us","language":"en","title":"3 Dow Stocks That Make for Screaming Buys in February","url":"https://stock-news.laohu8.com/highlight/detail?id=1158764094","media":"Motley Fool","summary":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock inde","content":"<html><head></head><body><h3>KEY POINTS</h3><ul><li>The 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.</li><li>The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.</li><li>These three Dow stocks offer bountiful catalysts and are reasonably cheap.</li></ul><p>Out of the Dow Jones Industrial Average&#39;s 30 components, there are three amazing deals hiding in plain sight.</p><p>It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.</p><p>But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably &#34;better&#34; than the 19% and 33% respective declines delivered by the S&amp;P 500 and Nasdaq Composite in 2022.</p><p>Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it&#39;s well equipped to deal with stock market downturns. It&#39;s also a great place to look for investing ideas during a bear market.</p><p>As we motor ahead into February, the following three Dow stocks stand out as screaming buys.</p><h3><a href=\"https://laohu8.com/S/V\">Visa</a></h3><p>The first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.</p><p>The biggest knock against Visa is that it&#39;s cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.</p><p>What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa&#39;s shareholders.</p><p>Something else that doesn&#39;t hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.</p><p>But don&#39;t think for a moment the U.S. is Visa&#39;s only organic growth opportunity. There&#39;s a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa&#39;s cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.</p><p>Another key investment thesis with Visa that I&#39;ve driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.</p><p>With Visa valued at 24 times Wall Street&#39;s consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.</p><h3><a href=\"https://laohu8.com/S/VZ\">Verizon Communications</a></h3><p>A second Dow stock that&#39;s nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).</p><p>For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.</p><p>One factor clearly working in Verizon&#39;s favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don&#39;t meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.</p><p>The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company&#39;s wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.</p><p>But the unsung hero for Verizon might just be the resurgence it&#39;s seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon&#39;s operating cash flow and improve its operating margins.</p><p>Currently valued at a little over 8 times Wall Street&#39;s forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.</p><h3><a href=\"https://laohu8.com/S/JNJ\">Johnson &amp; Johnson</a></h3><p>The third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson &amp; Johnson (JNJ 0.38%). J&amp;J, as Johnson &amp; Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.</p><p>Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can&#39;t decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It&#39;s this demand predictability that&#39;s kept Johnson &amp; Johnson&#39;s profit needle pointing higher for decades.</p><p>In terms of operating segments, pharmaceuticals are J&amp;J&#39;s not-so-subtle secret to success. For more than a decade, Johnson &amp; Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.</p><p>If there&#39;s a potential downside to having more than half of its sales come from pharmaceuticals, it&#39;s that sales exclusivity for brand-name drugs is finite. But J&amp;J has all the right answers to this possible headwind. It&#39;s devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that&#39;s well positioned to take advantage of an aging global population.</p><p>One of Johnson &amp; Johnson&#39;s bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&amp;J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street&#39;s 2023 consensus), which is where it ended this past week.</p><p>Lastly, Johnson &amp; Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it&#39;s one of only two with the highest possible credit rating (AAA) from Standard &amp; Poor&#39;s, a division of S&amp;P Global. It&#39;s also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson &amp; Johnson.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Dow Stocks That Make for Screaming Buys in February</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Dow Stocks That Make for Screaming Buys in February\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-02-04 00:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"V":"Visa","VZ":"威瑞森","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158764094","content_text":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.These three Dow stocks offer bountiful catalysts and are reasonably cheap.Out of the Dow Jones Industrial Average's 30 components, there are three amazing deals hiding in plain sight.It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably \"better\" than the 19% and 33% respective declines delivered by the S&P 500 and Nasdaq Composite in 2022.Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it's well equipped to deal with stock market downturns. It's also a great place to look for investing ideas during a bear market.As we motor ahead into February, the following three Dow stocks stand out as screaming buys.VisaThe first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.The biggest knock against Visa is that it's cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa's shareholders.Something else that doesn't hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.But don't think for a moment the U.S. is Visa's only organic growth opportunity. There's a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa's cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.Another key investment thesis with Visa that I've driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.With Visa valued at 24 times Wall Street's consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.Verizon CommunicationsA second Dow stock that's nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.One factor clearly working in Verizon's favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don't meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company's wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.But the unsung hero for Verizon might just be the resurgence it's seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon's operating cash flow and improve its operating margins.Currently valued at a little over 8 times Wall Street's forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.Johnson & JohnsonThe third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson & Johnson (JNJ 0.38%). J&J, as Johnson & Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can't decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It's this demand predictability that's kept Johnson & Johnson's profit needle pointing higher for decades.In terms of operating segments, pharmaceuticals are J&J's not-so-subtle secret to success. For more than a decade, Johnson & Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.If there's a potential downside to having more than half of its sales come from pharmaceuticals, it's that sales exclusivity for brand-name drugs is finite. But J&J has all the right answers to this possible headwind. It's devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that's well positioned to take advantage of an aging global population.One of Johnson & Johnson's bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street's 2023 consensus), which is where it ended this past week.Lastly, Johnson & Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it's one of only two with the highest possible credit rating (AAA) from Standard & Poor's, a division of S&P Global. It's also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson & Johnson.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9955260592,"gmtCreate":1675462999416,"gmtModify":1676539004265,"author":{"id":"3586435146520478","authorId":"3586435146520478","name":"Azzu","avatar":"https://community-static.tradeup.com/news/27ebb39698a1de55ebe2c3c3fd674003","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9955260592","repostId":1158764094,"repostType":2,"repost":{"id":"1158764094","pubTimestamp":1675440053,"share":"https://www.laohu8.com/m/news/1158764094?lang=&edition=full","pubTime":"2023-02-04 00:00","market":"us","language":"en","title":"3 Dow Stocks That Make for Screaming Buys in February","url":"https://stock-news.laohu8.com/highlight/detail?id=1158764094","media":"Motley Fool","summary":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock inde","content":"<html><head></head><body><h3>KEY POINTS</h3><ul><li>The 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.</li><li>The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.</li><li>These three Dow stocks offer bountiful catalysts and are reasonably cheap.</li></ul><p>Out of the Dow Jones Industrial Average&#39;s 30 components, there are three amazing deals hiding in plain sight.</p><p>It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.</p><p>But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably &#34;better&#34; than the 19% and 33% respective declines delivered by the S&amp;P 500 and Nasdaq Composite in 2022.</p><p>Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it&#39;s well equipped to deal with stock market downturns. It&#39;s also a great place to look for investing ideas during a bear market.</p><p>As we motor ahead into February, the following three Dow stocks stand out as screaming buys.</p><h3><a href=\"https://laohu8.com/S/V\">Visa</a></h3><p>The first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.</p><p>The biggest knock against Visa is that it&#39;s cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.</p><p>What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa&#39;s shareholders.</p><p>Something else that doesn&#39;t hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.</p><p>But don&#39;t think for a moment the U.S. is Visa&#39;s only organic growth opportunity. There&#39;s a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa&#39;s cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.</p><p>Another key investment thesis with Visa that I&#39;ve driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.</p><p>With Visa valued at 24 times Wall Street&#39;s consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.</p><h3><a href=\"https://laohu8.com/S/VZ\">Verizon Communications</a></h3><p>A second Dow stock that&#39;s nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).</p><p>For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.</p><p>One factor clearly working in Verizon&#39;s favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don&#39;t meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.</p><p>The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company&#39;s wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.</p><p>But the unsung hero for Verizon might just be the resurgence it&#39;s seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon&#39;s operating cash flow and improve its operating margins.</p><p>Currently valued at a little over 8 times Wall Street&#39;s forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.</p><h3><a href=\"https://laohu8.com/S/JNJ\">Johnson &amp; Johnson</a></h3><p>The third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson &amp; Johnson (JNJ 0.38%). J&amp;J, as Johnson &amp; Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.</p><p>Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can&#39;t decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It&#39;s this demand predictability that&#39;s kept Johnson &amp; Johnson&#39;s profit needle pointing higher for decades.</p><p>In terms of operating segments, pharmaceuticals are J&amp;J&#39;s not-so-subtle secret to success. For more than a decade, Johnson &amp; Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.</p><p>If there&#39;s a potential downside to having more than half of its sales come from pharmaceuticals, it&#39;s that sales exclusivity for brand-name drugs is finite. But J&amp;J has all the right answers to this possible headwind. It&#39;s devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that&#39;s well positioned to take advantage of an aging global population.</p><p>One of Johnson &amp; Johnson&#39;s bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&amp;J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street&#39;s 2023 consensus), which is where it ended this past week.</p><p>Lastly, Johnson &amp; Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it&#39;s one of only two with the highest possible credit rating (AAA) from Standard &amp; Poor&#39;s, a division of S&amp;P Global. It&#39;s also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson &amp; Johnson.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Dow Stocks That Make for Screaming Buys in February</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Dow Stocks That Make for Screaming Buys in February\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-02-04 00:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"V":"Visa","VZ":"威瑞森","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158764094","content_text":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.These three Dow stocks offer bountiful catalysts and are reasonably cheap.Out of the Dow Jones Industrial Average's 30 components, there are three amazing deals hiding in plain sight.It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably \"better\" than the 19% and 33% respective declines delivered by the S&P 500 and Nasdaq Composite in 2022.Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it's well equipped to deal with stock market downturns. It's also a great place to look for investing ideas during a bear market.As we motor ahead into February, the following three Dow stocks stand out as screaming buys.VisaThe first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.The biggest knock against Visa is that it's cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa's shareholders.Something else that doesn't hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.But don't think for a moment the U.S. is Visa's only organic growth opportunity. There's a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa's cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.Another key investment thesis with Visa that I've driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.With Visa valued at 24 times Wall Street's consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.Verizon CommunicationsA second Dow stock that's nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.One factor clearly working in Verizon's favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don't meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company's wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.But the unsung hero for Verizon might just be the resurgence it's seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon's operating cash flow and improve its operating margins.Currently valued at a little over 8 times Wall Street's forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.Johnson & JohnsonThe third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson & Johnson (JNJ 0.38%). J&J, as Johnson & Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can't decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It's this demand predictability that's kept Johnson & Johnson's profit needle pointing higher for decades.In terms of operating segments, pharmaceuticals are J&J's not-so-subtle secret to success. For more than a decade, Johnson & Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.If there's a potential downside to having more than half of its sales come from pharmaceuticals, it's that sales exclusivity for brand-name drugs is finite. But J&J has all the right answers to this possible headwind. It's devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that's well positioned to take advantage of an aging global population.One of Johnson & Johnson's bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street's 2023 consensus), which is where it ended this past week.Lastly, Johnson & Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it's one of only two with the highest possible credit rating (AAA) from Standard & Poor's, a division of S&P Global. It's also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson & Johnson.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9955284777,"gmtCreate":1675461994400,"gmtModify":1676539004217,"author":{"id":"3570342809089528","authorId":"3570342809089528","name":"phantom74","avatar":"https://static.tigerbbs.com/c87ef2af41b8696be86cceafb5b5723d","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":3,"crmLevelSwitch":0},"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9955284777","repostId":1158764094,"repostType":4,"repost":{"id":"1158764094","pubTimestamp":1675440053,"share":"https://www.laohu8.com/m/news/1158764094?lang=&edition=full","pubTime":"2023-02-04 00:00","market":"us","language":"en","title":"3 Dow Stocks That Make for Screaming Buys in February","url":"https://stock-news.laohu8.com/highlight/detail?id=1158764094","media":"Motley Fool","summary":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock inde","content":"<html><head></head><body><h3>KEY POINTS</h3><ul><li>The 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.</li><li>The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.</li><li>These three Dow stocks offer bountiful catalysts and are reasonably cheap.</li></ul><p>Out of the Dow Jones Industrial Average&#39;s 30 components, there are three amazing deals hiding in plain sight.</p><p>It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.</p><p>But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably &#34;better&#34; than the 19% and 33% respective declines delivered by the S&amp;P 500 and Nasdaq Composite in 2022.</p><p>Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it&#39;s well equipped to deal with stock market downturns. It&#39;s also a great place to look for investing ideas during a bear market.</p><p>As we motor ahead into February, the following three Dow stocks stand out as screaming buys.</p><h3><a href=\"https://laohu8.com/S/V\">Visa</a></h3><p>The first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.</p><p>The biggest knock against Visa is that it&#39;s cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.</p><p>What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa&#39;s shareholders.</p><p>Something else that doesn&#39;t hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.</p><p>But don&#39;t think for a moment the U.S. is Visa&#39;s only organic growth opportunity. There&#39;s a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa&#39;s cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.</p><p>Another key investment thesis with Visa that I&#39;ve driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.</p><p>With Visa valued at 24 times Wall Street&#39;s consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.</p><h3><a href=\"https://laohu8.com/S/VZ\">Verizon Communications</a></h3><p>A second Dow stock that&#39;s nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).</p><p>For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.</p><p>One factor clearly working in Verizon&#39;s favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don&#39;t meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.</p><p>The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company&#39;s wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.</p><p>But the unsung hero for Verizon might just be the resurgence it&#39;s seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon&#39;s operating cash flow and improve its operating margins.</p><p>Currently valued at a little over 8 times Wall Street&#39;s forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.</p><h3><a href=\"https://laohu8.com/S/JNJ\">Johnson &amp; Johnson</a></h3><p>The third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson &amp; Johnson (JNJ 0.38%). J&amp;J, as Johnson &amp; Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.</p><p>Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can&#39;t decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It&#39;s this demand predictability that&#39;s kept Johnson &amp; Johnson&#39;s profit needle pointing higher for decades.</p><p>In terms of operating segments, pharmaceuticals are J&amp;J&#39;s not-so-subtle secret to success. For more than a decade, Johnson &amp; Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.</p><p>If there&#39;s a potential downside to having more than half of its sales come from pharmaceuticals, it&#39;s that sales exclusivity for brand-name drugs is finite. But J&amp;J has all the right answers to this possible headwind. It&#39;s devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that&#39;s well positioned to take advantage of an aging global population.</p><p>One of Johnson &amp; Johnson&#39;s bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&amp;J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street&#39;s 2023 consensus), which is where it ended this past week.</p><p>Lastly, Johnson &amp; Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it&#39;s one of only two with the highest possible credit rating (AAA) from Standard &amp; Poor&#39;s, a division of S&amp;P Global. It&#39;s also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson &amp; Johnson.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Dow Stocks That Make for Screaming Buys in February</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Dow Stocks That Make for Screaming Buys in February\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-02-04 00:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"V":"Visa","VZ":"威瑞森","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158764094","content_text":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.These three Dow stocks offer bountiful catalysts and are reasonably cheap.Out of the Dow Jones Industrial Average's 30 components, there are three amazing deals hiding in plain sight.It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably \"better\" than the 19% and 33% respective declines delivered by the S&P 500 and Nasdaq Composite in 2022.Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it's well equipped to deal with stock market downturns. It's also a great place to look for investing ideas during a bear market.As we motor ahead into February, the following three Dow stocks stand out as screaming buys.VisaThe first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.The biggest knock against Visa is that it's cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa's shareholders.Something else that doesn't hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.But don't think for a moment the U.S. is Visa's only organic growth opportunity. There's a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa's cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.Another key investment thesis with Visa that I've driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.With Visa valued at 24 times Wall Street's consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.Verizon CommunicationsA second Dow stock that's nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.One factor clearly working in Verizon's favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don't meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company's wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.But the unsung hero for Verizon might just be the resurgence it's seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon's operating cash flow and improve its operating margins.Currently valued at a little over 8 times Wall Street's forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.Johnson & JohnsonThe third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson & Johnson (JNJ 0.38%). J&J, as Johnson & Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can't decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It's this demand predictability that's kept Johnson & Johnson's profit needle pointing higher for decades.In terms of operating segments, pharmaceuticals are J&J's not-so-subtle secret to success. For more than a decade, Johnson & Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.If there's a potential downside to having more than half of its sales come from pharmaceuticals, it's that sales exclusivity for brand-name drugs is finite. But J&J has all the right answers to this possible headwind. It's devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that's well positioned to take advantage of an aging global population.One of Johnson & Johnson's bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street's 2023 consensus), which is where it ended this past week.Lastly, Johnson & Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it's one of only two with the highest possible credit rating (AAA) from Standard & Poor's, a division of S&P Global. It's also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson & Johnson.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":105718973,"gmtCreate":1675464561418,"gmtModify":1675464565214,"authorId":3558617926022722,"author":{"id":3558617926022722,"authorId":3558617926022722,"name":"kkennn","avatar":"https://static.tigerbbs.com/cfb6967409b5a69e663a7006e885e221","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9955284777,"type":1,"supId":0,"prevId":0,"content":"<u>Ok</u>","text":"<u>Ok</u>","html":"<u>Ok</u>"}],"langContent":"EN"},{"id":9955284909,"gmtCreate":1675460780601,"gmtModify":1676539004199,"author":{"id":"3572830110372716","authorId":"3572830110372716","name":"KCtan1688","avatar":"https://static.tigerbbs.com/eb264e77c49fffb1d26a89a47dbc0250","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9955284909","repostId":1158764094,"repostType":4,"repost":{"id":"1158764094","pubTimestamp":1675440053,"share":"https://www.laohu8.com/m/news/1158764094?lang=&edition=full","pubTime":"2023-02-04 00:00","market":"us","language":"en","title":"3 Dow Stocks That Make for Screaming Buys in February","url":"https://stock-news.laohu8.com/highlight/detail?id=1158764094","media":"Motley Fool","summary":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock inde","content":"<html><head></head><body><h3>KEY POINTS</h3><ul><li>The 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.</li><li>The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.</li><li>These three Dow stocks offer bountiful catalysts and are reasonably cheap.</li></ul><p>Out of the Dow Jones Industrial Average&#39;s 30 components, there are three amazing deals hiding in plain sight.</p><p>It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.</p><p>But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably &#34;better&#34; than the 19% and 33% respective declines delivered by the S&amp;P 500 and Nasdaq Composite in 2022.</p><p>Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it&#39;s well equipped to deal with stock market downturns. It&#39;s also a great place to look for investing ideas during a bear market.</p><p>As we motor ahead into February, the following three Dow stocks stand out as screaming buys.</p><h3><a href=\"https://laohu8.com/S/V\">Visa</a></h3><p>The first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.</p><p>The biggest knock against Visa is that it&#39;s cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.</p><p>What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa&#39;s shareholders.</p><p>Something else that doesn&#39;t hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.</p><p>But don&#39;t think for a moment the U.S. is Visa&#39;s only organic growth opportunity. There&#39;s a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa&#39;s cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.</p><p>Another key investment thesis with Visa that I&#39;ve driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.</p><p>With Visa valued at 24 times Wall Street&#39;s consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.</p><h3><a href=\"https://laohu8.com/S/VZ\">Verizon Communications</a></h3><p>A second Dow stock that&#39;s nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).</p><p>For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.</p><p>One factor clearly working in Verizon&#39;s favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don&#39;t meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.</p><p>The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company&#39;s wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.</p><p>But the unsung hero for Verizon might just be the resurgence it&#39;s seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon&#39;s operating cash flow and improve its operating margins.</p><p>Currently valued at a little over 8 times Wall Street&#39;s forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.</p><h3><a href=\"https://laohu8.com/S/JNJ\">Johnson &amp; Johnson</a></h3><p>The third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson &amp; Johnson (JNJ 0.38%). J&amp;J, as Johnson &amp; Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.</p><p>Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can&#39;t decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It&#39;s this demand predictability that&#39;s kept Johnson &amp; Johnson&#39;s profit needle pointing higher for decades.</p><p>In terms of operating segments, pharmaceuticals are J&amp;J&#39;s not-so-subtle secret to success. For more than a decade, Johnson &amp; Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.</p><p>If there&#39;s a potential downside to having more than half of its sales come from pharmaceuticals, it&#39;s that sales exclusivity for brand-name drugs is finite. But J&amp;J has all the right answers to this possible headwind. It&#39;s devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that&#39;s well positioned to take advantage of an aging global population.</p><p>One of Johnson &amp; Johnson&#39;s bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&amp;J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street&#39;s 2023 consensus), which is where it ended this past week.</p><p>Lastly, Johnson &amp; Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it&#39;s one of only two with the highest possible credit rating (AAA) from Standard &amp; Poor&#39;s, a division of S&amp;P Global. It&#39;s also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson &amp; Johnson.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Dow Stocks That Make for Screaming Buys in February</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Dow Stocks That Make for Screaming Buys in February\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-02-04 00:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"V":"Visa","VZ":"威瑞森","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158764094","content_text":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.These three Dow stocks offer bountiful catalysts and are reasonably cheap.Out of the Dow Jones Industrial Average's 30 components, there are three amazing deals hiding in plain sight.It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably \"better\" than the 19% and 33% respective declines delivered by the S&P 500 and Nasdaq Composite in 2022.Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it's well equipped to deal with stock market downturns. It's also a great place to look for investing ideas during a bear market.As we motor ahead into February, the following three Dow stocks stand out as screaming buys.VisaThe first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.The biggest knock against Visa is that it's cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa's shareholders.Something else that doesn't hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.But don't think for a moment the U.S. is Visa's only organic growth opportunity. There's a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa's cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.Another key investment thesis with Visa that I've driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.With Visa valued at 24 times Wall Street's consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.Verizon CommunicationsA second Dow stock that's nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.One factor clearly working in Verizon's favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don't meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company's wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.But the unsung hero for Verizon might just be the resurgence it's seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon's operating cash flow and improve its operating margins.Currently valued at a little over 8 times Wall Street's forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.Johnson & JohnsonThe third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson & Johnson (JNJ 0.38%). J&J, as Johnson & Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can't decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It's this demand predictability that's kept Johnson & Johnson's profit needle pointing higher for decades.In terms of operating segments, pharmaceuticals are J&J's not-so-subtle secret to success. For more than a decade, Johnson & Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.If there's a potential downside to having more than half of its sales come from pharmaceuticals, it's that sales exclusivity for brand-name drugs is finite. But J&J has all the right answers to this possible headwind. It's devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that's well positioned to take advantage of an aging global population.One of Johnson & Johnson's bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street's 2023 consensus), which is where it ended this past week.Lastly, Johnson & Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it's one of only two with the highest possible credit rating (AAA) from Standard & Poor's, a division of S&P Global. It's also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson & Johnson.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":105718773,"gmtCreate":1675460790240,"gmtModify":1675460793766,"authorId":3572830110372716,"author":{"id":3572830110372716,"authorId":3572830110372716,"name":"KCtan1688","avatar":"https://static.tigerbbs.com/eb264e77c49fffb1d26a89a47dbc0250","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9955284909,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">Like</span>","text":"<span class=\"s1\">Like</span>","html":"<span class=\"s1\">Like</span>"}],"langContent":"EN"},{"id":9955285431,"gmtCreate":1675459552124,"gmtModify":1676539004170,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":2,"crmLevelSwitch":1},"htmlText":"Visa good for nothing.","listText":"Visa good for nothing.","text":"Visa good for nothing.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9955285431","repostId":1158764094,"repostType":4,"repost":{"id":"1158764094","pubTimestamp":1675440053,"share":"https://www.laohu8.com/m/news/1158764094?lang=&edition=full","pubTime":"2023-02-04 00:00","market":"us","language":"en","title":"3 Dow Stocks That Make for Screaming Buys in February","url":"https://stock-news.laohu8.com/highlight/detail?id=1158764094","media":"Motley Fool","summary":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock inde","content":"<html><head></head><body><h3>KEY POINTS</h3><ul><li>The 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.</li><li>The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.</li><li>These three Dow stocks offer bountiful catalysts and are reasonably cheap.</li></ul><p>Out of the Dow Jones Industrial Average&#39;s 30 components, there are three amazing deals hiding in plain sight.</p><p>It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.</p><p>But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably &#34;better&#34; than the 19% and 33% respective declines delivered by the S&amp;P 500 and Nasdaq Composite in 2022.</p><p>Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it&#39;s well equipped to deal with stock market downturns. It&#39;s also a great place to look for investing ideas during a bear market.</p><p>As we motor ahead into February, the following three Dow stocks stand out as screaming buys.</p><h3><a href=\"https://laohu8.com/S/V\">Visa</a></h3><p>The first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.</p><p>The biggest knock against Visa is that it&#39;s cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.</p><p>What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa&#39;s shareholders.</p><p>Something else that doesn&#39;t hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.</p><p>But don&#39;t think for a moment the U.S. is Visa&#39;s only organic growth opportunity. There&#39;s a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa&#39;s cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.</p><p>Another key investment thesis with Visa that I&#39;ve driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.</p><p>With Visa valued at 24 times Wall Street&#39;s consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.</p><h3><a href=\"https://laohu8.com/S/VZ\">Verizon Communications</a></h3><p>A second Dow stock that&#39;s nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).</p><p>For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.</p><p>One factor clearly working in Verizon&#39;s favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don&#39;t meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.</p><p>The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company&#39;s wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.</p><p>But the unsung hero for Verizon might just be the resurgence it&#39;s seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon&#39;s operating cash flow and improve its operating margins.</p><p>Currently valued at a little over 8 times Wall Street&#39;s forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.</p><h3><a href=\"https://laohu8.com/S/JNJ\">Johnson &amp; Johnson</a></h3><p>The third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson &amp; Johnson (JNJ 0.38%). J&amp;J, as Johnson &amp; Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.</p><p>Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can&#39;t decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It&#39;s this demand predictability that&#39;s kept Johnson &amp; Johnson&#39;s profit needle pointing higher for decades.</p><p>In terms of operating segments, pharmaceuticals are J&amp;J&#39;s not-so-subtle secret to success. For more than a decade, Johnson &amp; Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.</p><p>If there&#39;s a potential downside to having more than half of its sales come from pharmaceuticals, it&#39;s that sales exclusivity for brand-name drugs is finite. But J&amp;J has all the right answers to this possible headwind. It&#39;s devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that&#39;s well positioned to take advantage of an aging global population.</p><p>One of Johnson &amp; Johnson&#39;s bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&amp;J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street&#39;s 2023 consensus), which is where it ended this past week.</p><p>Lastly, Johnson &amp; Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it&#39;s one of only two with the highest possible credit rating (AAA) from Standard &amp; Poor&#39;s, a division of S&amp;P Global. It&#39;s also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson &amp; Johnson.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Dow Stocks That Make for Screaming Buys in February</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Dow Stocks That Make for Screaming Buys in February\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-02-04 00:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"V":"Visa","VZ":"威瑞森","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158764094","content_text":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.These three Dow stocks offer bountiful catalysts and are reasonably cheap.Out of the Dow Jones Industrial Average's 30 components, there are three amazing deals hiding in plain sight.It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably \"better\" than the 19% and 33% respective declines delivered by the S&P 500 and Nasdaq Composite in 2022.Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it's well equipped to deal with stock market downturns. It's also a great place to look for investing ideas during a bear market.As we motor ahead into February, the following three Dow stocks stand out as screaming buys.VisaThe first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.The biggest knock against Visa is that it's cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa's shareholders.Something else that doesn't hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.But don't think for a moment the U.S. is Visa's only organic growth opportunity. There's a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa's cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.Another key investment thesis with Visa that I've driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.With Visa valued at 24 times Wall Street's consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.Verizon CommunicationsA second Dow stock that's nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.One factor clearly working in Verizon's favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don't meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company's wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.But the unsung hero for Verizon might just be the resurgence it's seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon's operating cash flow and improve its operating margins.Currently valued at a little over 8 times Wall Street's forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.Johnson & JohnsonThe third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson & Johnson (JNJ 0.38%). J&J, as Johnson & Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can't decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It's this demand predictability that's kept Johnson & Johnson's profit needle pointing higher for decades.In terms of operating segments, pharmaceuticals are J&J's not-so-subtle secret to success. For more than a decade, Johnson & Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.If there's a potential downside to having more than half of its sales come from pharmaceuticals, it's that sales exclusivity for brand-name drugs is finite. But J&J has all the right answers to this possible headwind. It's devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that's well positioned to take advantage of an aging global population.One of Johnson & Johnson's bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street's 2023 consensus), which is where it ended this past week.Lastly, Johnson & Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it's one of only two with the highest possible credit rating (AAA) from Standard & Poor's, a division of S&P Global. It's also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson & Johnson.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":105718917,"gmtCreate":1675463013883,"gmtModify":1675463023190,"authorId":3586435146520478,"author":{"id":3586435146520478,"authorId":3586435146520478,"name":"Azzu","avatar":"https://community-static.tradeup.com/news/27ebb39698a1de55ebe2c3c3fd674003","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9955285431,"type":1,"supId":0,"prevId":0,"content":"[Cool]","text":"[Cool]","html":"[Cool]"}],"langContent":"EN"},{"id":9955289747,"gmtCreate":1675449697689,"gmtModify":1676539003917,"author":{"id":"3574813964437135","authorId":"3574813964437135","name":"June_C","avatar":"https://static.tigerbbs.com/ae77017e1795eeceab087663e5586137","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9955289747","repostId":1158764094,"repostType":4,"repost":{"id":"1158764094","pubTimestamp":1675440053,"share":"https://www.laohu8.com/m/news/1158764094?lang=&edition=full","pubTime":"2023-02-04 00:00","market":"us","language":"en","title":"3 Dow Stocks That Make for Screaming Buys in February","url":"https://stock-news.laohu8.com/highlight/detail?id=1158764094","media":"Motley Fool","summary":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock inde","content":"<html><head></head><body><h3>KEY POINTS</h3><ul><li>The 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.</li><li>The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.</li><li>These three Dow stocks offer bountiful catalysts and are reasonably cheap.</li></ul><p>Out of the Dow Jones Industrial Average&#39;s 30 components, there are three amazing deals hiding in plain sight.</p><p>It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.</p><p>But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably &#34;better&#34; than the 19% and 33% respective declines delivered by the S&amp;P 500 and Nasdaq Composite in 2022.</p><p>Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it&#39;s well equipped to deal with stock market downturns. It&#39;s also a great place to look for investing ideas during a bear market.</p><p>As we motor ahead into February, the following three Dow stocks stand out as screaming buys.</p><h3><a href=\"https://laohu8.com/S/V\">Visa</a></h3><p>The first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.</p><p>The biggest knock against Visa is that it&#39;s cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.</p><p>What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa&#39;s shareholders.</p><p>Something else that doesn&#39;t hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.</p><p>But don&#39;t think for a moment the U.S. is Visa&#39;s only organic growth opportunity. There&#39;s a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa&#39;s cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.</p><p>Another key investment thesis with Visa that I&#39;ve driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.</p><p>With Visa valued at 24 times Wall Street&#39;s consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.</p><h3><a href=\"https://laohu8.com/S/VZ\">Verizon Communications</a></h3><p>A second Dow stock that&#39;s nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).</p><p>For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.</p><p>One factor clearly working in Verizon&#39;s favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don&#39;t meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.</p><p>The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company&#39;s wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.</p><p>But the unsung hero for Verizon might just be the resurgence it&#39;s seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon&#39;s operating cash flow and improve its operating margins.</p><p>Currently valued at a little over 8 times Wall Street&#39;s forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.</p><h3><a href=\"https://laohu8.com/S/JNJ\">Johnson &amp; Johnson</a></h3><p>The third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson &amp; Johnson (JNJ 0.38%). J&amp;J, as Johnson &amp; Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.</p><p>Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can&#39;t decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It&#39;s this demand predictability that&#39;s kept Johnson &amp; Johnson&#39;s profit needle pointing higher for decades.</p><p>In terms of operating segments, pharmaceuticals are J&amp;J&#39;s not-so-subtle secret to success. For more than a decade, Johnson &amp; Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.</p><p>If there&#39;s a potential downside to having more than half of its sales come from pharmaceuticals, it&#39;s that sales exclusivity for brand-name drugs is finite. But J&amp;J has all the right answers to this possible headwind. It&#39;s devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that&#39;s well positioned to take advantage of an aging global population.</p><p>One of Johnson &amp; Johnson&#39;s bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&amp;J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street&#39;s 2023 consensus), which is where it ended this past week.</p><p>Lastly, Johnson &amp; Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it&#39;s one of only two with the highest possible credit rating (AAA) from Standard &amp; Poor&#39;s, a division of S&amp;P Global. It&#39;s also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson &amp; Johnson.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Dow Stocks That Make for Screaming Buys in February</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Dow Stocks That Make for Screaming Buys in February\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-02-04 00:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"V":"Visa","VZ":"威瑞森","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158764094","content_text":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.These three Dow stocks offer bountiful catalysts and are reasonably cheap.Out of the Dow Jones Industrial Average's 30 components, there are three amazing deals hiding in plain sight.It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably \"better\" than the 19% and 33% respective declines delivered by the S&P 500 and Nasdaq Composite in 2022.Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it's well equipped to deal with stock market downturns. It's also a great place to look for investing ideas during a bear market.As we motor ahead into February, the following three Dow stocks stand out as screaming buys.VisaThe first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.The biggest knock against Visa is that it's cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa's shareholders.Something else that doesn't hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.But don't think for a moment the U.S. is Visa's only organic growth opportunity. There's a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa's cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.Another key investment thesis with Visa that I've driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.With Visa valued at 24 times Wall Street's consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.Verizon CommunicationsA second Dow stock that's nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.One factor clearly working in Verizon's favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don't meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company's wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.But the unsung hero for Verizon might just be the resurgence it's seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon's operating cash flow and improve its operating margins.Currently valued at a little over 8 times Wall Street's forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.Johnson & JohnsonThe third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson & Johnson (JNJ 0.38%). J&J, as Johnson & Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can't decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It's this demand predictability that's kept Johnson & Johnson's profit needle pointing higher for decades.In terms of operating segments, pharmaceuticals are J&J's not-so-subtle secret to success. For more than a decade, Johnson & Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.If there's a potential downside to having more than half of its sales come from pharmaceuticals, it's that sales exclusivity for brand-name drugs is finite. But J&J has all the right answers to this possible headwind. It's devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that's well positioned to take advantage of an aging global population.One of Johnson & Johnson's bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street's 2023 consensus), which is where it ended this past week.Lastly, Johnson & Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it's one of only two with the highest possible credit rating (AAA) from Standard & Poor's, a division of S&P Global. It's also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson & Johnson.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9955206152,"gmtCreate":1675428526577,"gmtModify":1676539001959,"author":{"id":"4134278158747952","authorId":"4134278158747952","name":"LimBT","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":19,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9955206152","repostId":1158764094,"repostType":4,"repost":{"id":"1158764094","pubTimestamp":1675440053,"share":"https://www.laohu8.com/m/news/1158764094?lang=&edition=full","pubTime":"2023-02-04 00:00","market":"us","language":"en","title":"3 Dow Stocks That Make for Screaming Buys in February","url":"https://stock-news.laohu8.com/highlight/detail?id=1158764094","media":"Motley Fool","summary":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock inde","content":"<html><head></head><body><h3>KEY POINTS</h3><ul><li>The 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.</li><li>The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.</li><li>These three Dow stocks offer bountiful catalysts and are reasonably cheap.</li></ul><p>Out of the Dow Jones Industrial Average&#39;s 30 components, there are three amazing deals hiding in plain sight.</p><p>It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.</p><p>But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably &#34;better&#34; than the 19% and 33% respective declines delivered by the S&amp;P 500 and Nasdaq Composite in 2022.</p><p>Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it&#39;s well equipped to deal with stock market downturns. It&#39;s also a great place to look for investing ideas during a bear market.</p><p>As we motor ahead into February, the following three Dow stocks stand out as screaming buys.</p><h3><a href=\"https://laohu8.com/S/V\">Visa</a></h3><p>The first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.</p><p>The biggest knock against Visa is that it&#39;s cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.</p><p>What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa&#39;s shareholders.</p><p>Something else that doesn&#39;t hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.</p><p>But don&#39;t think for a moment the U.S. is Visa&#39;s only organic growth opportunity. There&#39;s a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa&#39;s cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.</p><p>Another key investment thesis with Visa that I&#39;ve driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.</p><p>With Visa valued at 24 times Wall Street&#39;s consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.</p><h3><a href=\"https://laohu8.com/S/VZ\">Verizon Communications</a></h3><p>A second Dow stock that&#39;s nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).</p><p>For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.</p><p>One factor clearly working in Verizon&#39;s favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don&#39;t meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.</p><p>The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company&#39;s wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.</p><p>But the unsung hero for Verizon might just be the resurgence it&#39;s seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon&#39;s operating cash flow and improve its operating margins.</p><p>Currently valued at a little over 8 times Wall Street&#39;s forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.</p><h3><a href=\"https://laohu8.com/S/JNJ\">Johnson &amp; Johnson</a></h3><p>The third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson &amp; Johnson (JNJ 0.38%). J&amp;J, as Johnson &amp; Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.</p><p>Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can&#39;t decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It&#39;s this demand predictability that&#39;s kept Johnson &amp; Johnson&#39;s profit needle pointing higher for decades.</p><p>In terms of operating segments, pharmaceuticals are J&amp;J&#39;s not-so-subtle secret to success. For more than a decade, Johnson &amp; Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.</p><p>If there&#39;s a potential downside to having more than half of its sales come from pharmaceuticals, it&#39;s that sales exclusivity for brand-name drugs is finite. But J&amp;J has all the right answers to this possible headwind. It&#39;s devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that&#39;s well positioned to take advantage of an aging global population.</p><p>One of Johnson &amp; Johnson&#39;s bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&amp;J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street&#39;s 2023 consensus), which is where it ended this past week.</p><p>Lastly, Johnson &amp; Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it&#39;s one of only two with the highest possible credit rating (AAA) from Standard &amp; Poor&#39;s, a division of S&amp;P Global. It&#39;s also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson &amp; Johnson.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Dow Stocks That Make for Screaming Buys in February</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Dow Stocks That Make for Screaming Buys in February\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-02-04 00:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"V":"Visa","VZ":"威瑞森","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158764094","content_text":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.These three Dow stocks offer bountiful catalysts and are reasonably cheap.Out of the Dow Jones Industrial Average's 30 components, there are three amazing deals hiding in plain sight.It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably \"better\" than the 19% and 33% respective declines delivered by the S&P 500 and Nasdaq Composite in 2022.Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it's well equipped to deal with stock market downturns. It's also a great place to look for investing ideas during a bear market.As we motor ahead into February, the following three Dow stocks stand out as screaming buys.VisaThe first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.The biggest knock against Visa is that it's cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa's shareholders.Something else that doesn't hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.But don't think for a moment the U.S. is Visa's only organic growth opportunity. There's a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa's cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.Another key investment thesis with Visa that I've driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.With Visa valued at 24 times Wall Street's consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.Verizon CommunicationsA second Dow stock that's nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.One factor clearly working in Verizon's favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don't meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company's wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.But the unsung hero for Verizon might just be the resurgence it's seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon's operating cash flow and improve its operating margins.Currently valued at a little over 8 times Wall Street's forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.Johnson & JohnsonThe third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson & Johnson (JNJ 0.38%). J&J, as Johnson & Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can't decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It's this demand predictability that's kept Johnson & Johnson's profit needle pointing higher for decades.In terms of operating segments, pharmaceuticals are J&J's not-so-subtle secret to success. For more than a decade, Johnson & Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.If there's a potential downside to having more than half of its sales come from pharmaceuticals, it's that sales exclusivity for brand-name drugs is finite. But J&J has all the right answers to this possible headwind. It's devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that's well positioned to take advantage of an aging global population.One of Johnson & Johnson's bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street's 2023 consensus), which is where it ended this past week.Lastly, Johnson & Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it's one of only two with the highest possible credit rating (AAA) from Standard & Poor's, a division of S&P Global. It's also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson & Johnson.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9955208843,"gmtCreate":1675426507682,"gmtModify":1676539001911,"author":{"id":"4112071922817752","authorId":"4112071922817752","name":"SNeo","avatar":"https://community-static.tradeup.com/news/d5b48d982c4246e1c1d0400e42ad5e32","vip":1,"crmLevel":2,"crmLevelSwitch":1},"htmlText":"[OK]&nbsp;","listText":"[OK]&nbsp;","text":"[OK]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9955208843","repostId":1158764094,"repostType":4,"repost":{"id":"1158764094","pubTimestamp":1675440053,"share":"https://www.laohu8.com/m/news/1158764094?lang=&edition=full","pubTime":"2023-02-04 00:00","market":"us","language":"en","title":"3 Dow Stocks That Make for Screaming Buys in February","url":"https://stock-news.laohu8.com/highlight/detail?id=1158764094","media":"Motley Fool","summary":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock inde","content":"<html><head></head><body><h3>KEY POINTS</h3><ul><li>The 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.</li><li>The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.</li><li>These three Dow stocks offer bountiful catalysts and are reasonably cheap.</li></ul><p>Out of the Dow Jones Industrial Average&#39;s 30 components, there are three amazing deals hiding in plain sight.</p><p>It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.</p><p>But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably &#34;better&#34; than the 19% and 33% respective declines delivered by the S&amp;P 500 and Nasdaq Composite in 2022.</p><p>Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it&#39;s well equipped to deal with stock market downturns. It&#39;s also a great place to look for investing ideas during a bear market.</p><p>As we motor ahead into February, the following three Dow stocks stand out as screaming buys.</p><h3><a href=\"https://laohu8.com/S/V\">Visa</a></h3><p>The first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.</p><p>The biggest knock against Visa is that it&#39;s cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.</p><p>What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa&#39;s shareholders.</p><p>Something else that doesn&#39;t hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.</p><p>But don&#39;t think for a moment the U.S. is Visa&#39;s only organic growth opportunity. There&#39;s a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa&#39;s cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.</p><p>Another key investment thesis with Visa that I&#39;ve driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.</p><p>With Visa valued at 24 times Wall Street&#39;s consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.</p><h3><a href=\"https://laohu8.com/S/VZ\">Verizon Communications</a></h3><p>A second Dow stock that&#39;s nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).</p><p>For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.</p><p>One factor clearly working in Verizon&#39;s favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don&#39;t meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.</p><p>The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company&#39;s wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.</p><p>But the unsung hero for Verizon might just be the resurgence it&#39;s seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon&#39;s operating cash flow and improve its operating margins.</p><p>Currently valued at a little over 8 times Wall Street&#39;s forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.</p><h3><a href=\"https://laohu8.com/S/JNJ\">Johnson &amp; Johnson</a></h3><p>The third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson &amp; Johnson (JNJ 0.38%). J&amp;J, as Johnson &amp; Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.</p><p>Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can&#39;t decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It&#39;s this demand predictability that&#39;s kept Johnson &amp; Johnson&#39;s profit needle pointing higher for decades.</p><p>In terms of operating segments, pharmaceuticals are J&amp;J&#39;s not-so-subtle secret to success. For more than a decade, Johnson &amp; Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.</p><p>If there&#39;s a potential downside to having more than half of its sales come from pharmaceuticals, it&#39;s that sales exclusivity for brand-name drugs is finite. But J&amp;J has all the right answers to this possible headwind. It&#39;s devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that&#39;s well positioned to take advantage of an aging global population.</p><p>One of Johnson &amp; Johnson&#39;s bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&amp;J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street&#39;s 2023 consensus), which is where it ended this past week.</p><p>Lastly, Johnson &amp; Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it&#39;s one of only two with the highest possible credit rating (AAA) from Standard &amp; Poor&#39;s, a division of S&amp;P Global. It&#39;s also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson &amp; Johnson.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Dow Stocks That Make for Screaming Buys in February</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Dow Stocks That Make for Screaming Buys in February\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-02-04 00:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"V":"Visa","VZ":"威瑞森","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158764094","content_text":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.These three Dow stocks offer bountiful catalysts and are reasonably cheap.Out of the Dow Jones Industrial Average's 30 components, there are three amazing deals hiding in plain sight.It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably \"better\" than the 19% and 33% respective declines delivered by the S&P 500 and Nasdaq Composite in 2022.Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it's well equipped to deal with stock market downturns. It's also a great place to look for investing ideas during a bear market.As we motor ahead into February, the following three Dow stocks stand out as screaming buys.VisaThe first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.The biggest knock against Visa is that it's cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa's shareholders.Something else that doesn't hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.But don't think for a moment the U.S. is Visa's only organic growth opportunity. There's a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa's cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.Another key investment thesis with Visa that I've driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.With Visa valued at 24 times Wall Street's consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.Verizon CommunicationsA second Dow stock that's nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.One factor clearly working in Verizon's favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don't meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company's wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.But the unsung hero for Verizon might just be the resurgence it's seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon's operating cash flow and improve its operating margins.Currently valued at a little over 8 times Wall Street's forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.Johnson & JohnsonThe third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson & Johnson (JNJ 0.38%). J&J, as Johnson & Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can't decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It's this demand predictability that's kept Johnson & Johnson's profit needle pointing higher for decades.In terms of operating segments, pharmaceuticals are J&J's not-so-subtle secret to success. For more than a decade, Johnson & Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.If there's a potential downside to having more than half of its sales come from pharmaceuticals, it's that sales exclusivity for brand-name drugs is finite. But J&J has all the right answers to this possible headwind. It's devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that's well positioned to take advantage of an aging global population.One of Johnson & Johnson's bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street's 2023 consensus), which is where it ended this past week.Lastly, Johnson & Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it's one of only two with the highest possible credit rating (AAA) from Standard & Poor's, a division of S&P Global. It's also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson & Johnson.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9955208357,"gmtCreate":1675426451280,"gmtModify":1676539001904,"author":{"id":"4097767435236930","authorId":"4097767435236930","name":"Aivern","avatar":"https://static.tigerbbs.com/3827d6c7271c872fcc616eaa9b4f7f54","vip":1,"crmLevel":3,"crmLevelSwitch":1},"htmlText":"Lol garbage","listText":"Lol garbage","text":"Lol garbage","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9955208357","repostId":1158764094,"repostType":2,"repost":{"id":"1158764094","pubTimestamp":1675440053,"share":"https://www.laohu8.com/m/news/1158764094?lang=&edition=full","pubTime":"2023-02-04 00:00","market":"us","language":"en","title":"3 Dow Stocks That Make for Screaming Buys in February","url":"https://stock-news.laohu8.com/highlight/detail?id=1158764094","media":"Motley Fool","summary":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock inde","content":"<html><head></head><body><h3>KEY POINTS</h3><ul><li>The 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.</li><li>The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.</li><li>These three Dow stocks offer bountiful catalysts and are reasonably cheap.</li></ul><p>Out of the Dow Jones Industrial Average&#39;s 30 components, there are three amazing deals hiding in plain sight.</p><p>It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.</p><p>But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably &#34;better&#34; than the 19% and 33% respective declines delivered by the S&amp;P 500 and Nasdaq Composite in 2022.</p><p>Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it&#39;s well equipped to deal with stock market downturns. It&#39;s also a great place to look for investing ideas during a bear market.</p><p>As we motor ahead into February, the following three Dow stocks stand out as screaming buys.</p><h3><a href=\"https://laohu8.com/S/V\">Visa</a></h3><p>The first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.</p><p>The biggest knock against Visa is that it&#39;s cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.</p><p>What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa&#39;s shareholders.</p><p>Something else that doesn&#39;t hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.</p><p>But don&#39;t think for a moment the U.S. is Visa&#39;s only organic growth opportunity. There&#39;s a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa&#39;s cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.</p><p>Another key investment thesis with Visa that I&#39;ve driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.</p><p>With Visa valued at 24 times Wall Street&#39;s consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.</p><h3><a href=\"https://laohu8.com/S/VZ\">Verizon Communications</a></h3><p>A second Dow stock that&#39;s nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).</p><p>For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.</p><p>One factor clearly working in Verizon&#39;s favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don&#39;t meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.</p><p>The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company&#39;s wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.</p><p>But the unsung hero for Verizon might just be the resurgence it&#39;s seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon&#39;s operating cash flow and improve its operating margins.</p><p>Currently valued at a little over 8 times Wall Street&#39;s forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.</p><h3><a href=\"https://laohu8.com/S/JNJ\">Johnson &amp; Johnson</a></h3><p>The third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson &amp; Johnson (JNJ 0.38%). J&amp;J, as Johnson &amp; Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.</p><p>Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can&#39;t decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It&#39;s this demand predictability that&#39;s kept Johnson &amp; Johnson&#39;s profit needle pointing higher for decades.</p><p>In terms of operating segments, pharmaceuticals are J&amp;J&#39;s not-so-subtle secret to success. For more than a decade, Johnson &amp; Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.</p><p>If there&#39;s a potential downside to having more than half of its sales come from pharmaceuticals, it&#39;s that sales exclusivity for brand-name drugs is finite. But J&amp;J has all the right answers to this possible headwind. It&#39;s devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that&#39;s well positioned to take advantage of an aging global population.</p><p>One of Johnson &amp; Johnson&#39;s bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&amp;J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street&#39;s 2023 consensus), which is where it ended this past week.</p><p>Lastly, Johnson &amp; Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it&#39;s one of only two with the highest possible credit rating (AAA) from Standard &amp; Poor&#39;s, a division of S&amp;P Global. It&#39;s also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson &amp; Johnson.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Dow Stocks That Make for Screaming Buys in February</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Dow Stocks That Make for Screaming Buys in February\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-02-04 00:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"V":"Visa","VZ":"威瑞森","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158764094","content_text":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.These three Dow stocks offer bountiful catalysts and are reasonably cheap.Out of the Dow Jones Industrial Average's 30 components, there are three amazing deals hiding in plain sight.It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably \"better\" than the 19% and 33% respective declines delivered by the S&P 500 and Nasdaq Composite in 2022.Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it's well equipped to deal with stock market downturns. It's also a great place to look for investing ideas during a bear market.As we motor ahead into February, the following three Dow stocks stand out as screaming buys.VisaThe first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.The biggest knock against Visa is that it's cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa's shareholders.Something else that doesn't hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.But don't think for a moment the U.S. is Visa's only organic growth opportunity. There's a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa's cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.Another key investment thesis with Visa that I've driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.With Visa valued at 24 times Wall Street's consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.Verizon CommunicationsA second Dow stock that's nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.One factor clearly working in Verizon's favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don't meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company's wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.But the unsung hero for Verizon might just be the resurgence it's seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon's operating cash flow and improve its operating margins.Currently valued at a little over 8 times Wall Street's forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.Johnson & JohnsonThe third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson & Johnson (JNJ 0.38%). J&J, as Johnson & Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can't decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It's this demand predictability that's kept Johnson & Johnson's profit needle pointing higher for decades.In terms of operating segments, pharmaceuticals are J&J's not-so-subtle secret to success. For more than a decade, Johnson & Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.If there's a potential downside to having more than half of its sales come from pharmaceuticals, it's that sales exclusivity for brand-name drugs is finite. But J&J has all the right answers to this possible headwind. It's devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that's well positioned to take advantage of an aging global population.One of Johnson & Johnson's bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street's 2023 consensus), which is where it ended this past week.Lastly, Johnson & Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it's one of only two with the highest possible credit rating (AAA) from Standard & Poor's, a division of S&P Global. It's also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson & Johnson.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9955201272,"gmtCreate":1675426083496,"gmtModify":1676539001888,"author":{"id":"4106387998711340","authorId":"4106387998711340","name":"JQC","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":14,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/9955201272","repostId":1158764094,"repostType":4,"repost":{"id":"1158764094","pubTimestamp":1675440053,"share":"https://www.laohu8.com/m/news/1158764094?lang=&edition=full","pubTime":"2023-02-04 00:00","market":"us","language":"en","title":"3 Dow Stocks That Make for Screaming Buys in February","url":"https://stock-news.laohu8.com/highlight/detail?id=1158764094","media":"Motley Fool","summary":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock inde","content":"<html><head></head><body><h3>KEY POINTS</h3><ul><li>The 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.</li><li>The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.</li><li>These three Dow stocks offer bountiful catalysts and are reasonably cheap.</li></ul><p>Out of the Dow Jones Industrial Average&#39;s 30 components, there are three amazing deals hiding in plain sight.</p><p>It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.</p><p>But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably &#34;better&#34; than the 19% and 33% respective declines delivered by the S&amp;P 500 and Nasdaq Composite in 2022.</p><p>Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it&#39;s well equipped to deal with stock market downturns. It&#39;s also a great place to look for investing ideas during a bear market.</p><p>As we motor ahead into February, the following three Dow stocks stand out as screaming buys.</p><h3><a href=\"https://laohu8.com/S/V\">Visa</a></h3><p>The first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.</p><p>The biggest knock against Visa is that it&#39;s cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.</p><p>What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa&#39;s shareholders.</p><p>Something else that doesn&#39;t hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.</p><p>But don&#39;t think for a moment the U.S. is Visa&#39;s only organic growth opportunity. There&#39;s a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa&#39;s cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.</p><p>Another key investment thesis with Visa that I&#39;ve driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.</p><p>With Visa valued at 24 times Wall Street&#39;s consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.</p><h3><a href=\"https://laohu8.com/S/VZ\">Verizon Communications</a></h3><p>A second Dow stock that&#39;s nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).</p><p>For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.</p><p>One factor clearly working in Verizon&#39;s favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don&#39;t meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.</p><p>The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company&#39;s wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.</p><p>But the unsung hero for Verizon might just be the resurgence it&#39;s seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon&#39;s operating cash flow and improve its operating margins.</p><p>Currently valued at a little over 8 times Wall Street&#39;s forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.</p><h3><a href=\"https://laohu8.com/S/JNJ\">Johnson &amp; Johnson</a></h3><p>The third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson &amp; Johnson (JNJ 0.38%). J&amp;J, as Johnson &amp; Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.</p><p>Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can&#39;t decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It&#39;s this demand predictability that&#39;s kept Johnson &amp; Johnson&#39;s profit needle pointing higher for decades.</p><p>In terms of operating segments, pharmaceuticals are J&amp;J&#39;s not-so-subtle secret to success. For more than a decade, Johnson &amp; Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.</p><p>If there&#39;s a potential downside to having more than half of its sales come from pharmaceuticals, it&#39;s that sales exclusivity for brand-name drugs is finite. But J&amp;J has all the right answers to this possible headwind. It&#39;s devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that&#39;s well positioned to take advantage of an aging global population.</p><p>One of Johnson &amp; Johnson&#39;s bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&amp;J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street&#39;s 2023 consensus), which is where it ended this past week.</p><p>Lastly, Johnson &amp; Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it&#39;s one of only two with the highest possible credit rating (AAA) from Standard &amp; Poor&#39;s, a division of S&amp;P Global. It&#39;s also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson &amp; Johnson.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Dow Stocks That Make for Screaming Buys in February</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Dow Stocks That Make for Screaming Buys in February\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-02-04 00:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"V":"Visa","VZ":"威瑞森","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158764094","content_text":"KEY POINTSThe 9% decline in the Dow Jones last year made it the top-performing major U.S. stock index.The Dow is made up of 30 generally profitable, time-tested businesses that can make for smart investments during a bear market.These three Dow stocks offer bountiful catalysts and are reasonably cheap.Out of the Dow Jones Industrial Average's 30 components, there are three amazing deals hiding in plain sight.It may not be a fun realization, but corrections, crashes, and bear markets are a normal part of the investing cycle. Last year served as this unpleasant reminder, with all three major U.S. stock indexes falling into a bear market.But among the major stock indexes, the Dow Jones Industrial Average (^DJI) stood head and shoulders above the pack. Its 9% loss was considerably \"better\" than the 19% and 33% respective declines delivered by the S&P 500 and Nasdaq Composite in 2022.Since the Dow Jones is a 30-component index packed with mature, profitable businesses, it's well equipped to deal with stock market downturns. It's also a great place to look for investing ideas during a bear market.As we motor ahead into February, the following three Dow stocks stand out as screaming buys.VisaThe first Dow Jones Industrial Average stock begging to be bought in February is payment-processing kingpin Visa.The biggest knock against Visa is that it's cyclical. Since recessions are an inevitable part of the economic cycle, Visa is bound to encounter a spending slowdown from consumers and businesses. But even if a recession were to materialize this year, investors should understand that economic downturns tend to be short lived.What makes Visa such a great company is its ability to grow in lockstep with the U.S. and global economy over time. In short, patience tends to pay off handsomely for Visa's shareholders.Something else that doesn't hurt is holding a majority of credit card network purchase volume in the No. 1 market for consumption in the world. As of 2021, Visa accounted for 52.6% of network purchase volume in the U.S. and was the only one of the four major payment networks to significantly increase its share following the Great Recession.But don't think for a moment the U.S. is Visa's only organic growth opportunity. There's a multidecade runway for Visa to organically expand into underbanked emerging markets with its payment infrastructure. Last year alone, Visa's cross-border payment volume, excluding transactions within Europe, soared 49%. This serves as confirmation that emerging markets can help Visa sustain a double-digit growth rate for a long time to come.Another key investment thesis with Visa that I've driven home repeatedly is the fiscal prudence of management. Although Visa could easily enter the lending arena, the company has chosen to strictly remain a payment processor. The advantage of avoiding this temptation is that it has no loan-loss liability during economic downturns. Not having to set aside billions of dollars in provisions to cover loan losses is a powerful advantage that helps Visa bounce back from recessions faster than most financial stocks.With Visa valued at 24 times Wall Street's consensus earnings for 2024, and the company capable of sustained double-digit sales growth, it looks like an incredible company at a very fair price.Verizon CommunicationsA second Dow stock that's nothing short of a screaming buy in February is telecom giant Verizon Communications. As of last weekend, Verizon was the highest-yielding Dow component (6.4% yield).For more than a decade, telecom stocks have been nothing more than an afterthought. Historically low lending rates made growth stocks far more attractive. But with interest rates climbing at their fastest pace in four decades and investors navigating their first extended bear market since 2009, value plays like Verizon are coming back into focus.One factor clearly working in Verizon's favor is the evolution of wireless service as a basic necessity. No matter how poorly the U.S. economy or stock market performs, wireless retail churn rates don't meaningfully rise. This leads to highly predictable cash flow for Verizon, which allows the company to confidently outlay capital for infrastructure projects and its dividend without any fear of adversely impacting its profitability.The 5G revolution is, arguably, the top catalyst for Verizon through at the least the midpoint of this decade. After approximately 10 years without any major wireless download speed improvements, 5G offers consumers and businesses a tangible lure to trade in their devices. Even though upgrading its wireless infrastructure will be costly and time consuming, the benefit for Verizon of users increasing their data consumption far outweighs the cost. The company's wireless service revenue rose nearly 6% last year, with retail postpaid net additions hitting a seven-year high.But the unsung hero for Verizon might just be the resurgence it's seen in broadband additions. After spending a small fortune to purchase mid-band spectrum for its 5G home and enterprise broadband services, Verizon registered 416,000 net broadband adds in the fourth quarter. That was its best quarter for broadband net additions in over a decade. The bundling potential broadband offers should boost Verizon's operating cash flow and improve its operating margins.Currently valued at a little over 8 times Wall Street's forecast earnings for 2023, Verizon and its 6%-plus yield offer an excellent risk-versus-reward for investors.Johnson & JohnsonThe third Dow Jones stock that makes for a screaming buy in February is none other than healthcare conglomerate Johnson & Johnson (JNJ 0.38%). J&J, as Johnson & Johnson is more commonly known, parses out a hearty 2.7% yield and has raised its annual payout for an impressive 60 straight years.Generally speaking, healthcare stocks make for smart buys during a bear market due to their defensive nature. Since we can't decide when we get sick or what ailment(s) we develop, there tends to be steady demand for prescription drugs, medical devices, and healthcare products and services, in any economic environment. It's this demand predictability that's kept Johnson & Johnson's profit needle pointing higher for decades.In terms of operating segments, pharmaceuticals are J&J's not-so-subtle secret to success. For more than a decade, Johnson & Johnson has shifted its focus to high-margin, fast-growing, brand-name therapeutics.If there's a potential downside to having more than half of its sales come from pharmaceuticals, it's that sales exclusivity for brand-name drugs is finite. But J&J has all the right answers to this possible headwind. It's devoting plenty of capital for internal research, has outlaid cash for numerous drug-development collaborations, and is even willing to make acquisitions. It also has an industry-leading medical technologies segment that's well positioned to take advantage of an aging global population.One of Johnson & Johnson's bigger catalysts in 2023 is the upcoming spinoff of its health products segment, which will be known as Kenvue. Once this spinoff is complete, J&J will sport a faster organic growth rate driven by pharmaceuticals and its MedTech segment, and will likely be deserving of an earnings multiple of more than 16 (based on Wall Street's 2023 consensus), which is where it ended this past week.Lastly, Johnson & Johnson is a company that even the most conservative investors can buy and hold with confidence. Out of the thousands of publicly traded companies, it's one of only two with the highest possible credit rating (AAA) from Standard & Poor's, a division of S&P Global. It's also had just 10 CEOs in its 137-year history. Therefore, there may not be a safer and steadier Dow component than Johnson & Johnson.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":105718874,"gmtCreate":1675462308054,"gmtModify":1675462311276,"authorId":4089289997531260,"author":{"id":4089289997531260,"authorId":4089289997531260,"name":"MilkyMiao","avatar":"https://static.tigerbbs.com/4ee9d59a462683a292a5e2ec5cc4c061","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9955201272,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">Ok</span>","text":"<span class=\"s1\">Ok</span>","html":"<span class=\"s1\">Ok</span>"},{"id":105718865,"gmtCreate":1675461875157,"gmtModify":1675461897697,"authorId":3581585697986903,"author":{"id":3581585697986903,"authorId":3581585697986903,"name":"Zeruel","avatar":"https://static.tigerbbs.com/eecf09841f50906eaebded07a6c16ff0","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9955201272,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">😡</span>","text":"<span class=\"s1\">😡</span>","html":"<span class=\"s1\">😡</span>"}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":247,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}